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 With conjugated materials being used in the development of new sensory devices 
for detection of metals, bacteria, and chemical warfare agents, the field of organic sensing 
is growing faster than ever. The purpose of this dissertation is to provide a precedence for 
the synthesis of new cross-conjugated compounds and outline potential applications of 
these materials as chemical sensors and molecular probes. 
 This dissertation is broken into two main sections: Chapters 1-4 primarily outline 
the synthesis of new compounds, wherein the principal goals were to design new cross-
conjugated architectures based on known molecules and to compare the spectroscopic 
properties with well-defined systems. The central theme of chapter 5-6 is the application 
of cross-conjugated materials in fluorescence sensing. In both chapters, the development 
of a three-molecule fluorophore array is discussed along with the ability to identify and 
discriminate between analytes using only digital photographs of fluorescence and 
statistical analysis. 
 This research serves as a meticulous examination into cross-conjugated materials 
and how alterations of the frontier molecular orbitals can be utilized for applications in 




INTRODUCTION AND OVERVIEW 
Motivation and Dissertation Overview 
 The field of organic electronics has blossomed into an area of highly competitive 
research resulting in many of the evolutionary leaps in modern technology that we have 
undergone in the past thirty years. With sub-topics including the development of organic 
solar cells, light emitting diodes, molecular probes and  sensors, and molecular transistors 
for use in device fabrication, organic electronics have come to the forefront of modern 
chemical research. As recent literature has shown, there is interest in the development 
and modification of molecular sensors for a vast array of applications. In the mid-1990s, 
poly(para-phenyleneethynylene)s (PPEs), began to gain prominence in the world of 






 Over the past decade, 
structural modifications in PPEs have yielded polymeric sensors capable of analyte 
detection in both organic and most importantly, aqueous solutions, a property that 
introduced PPEs as viable sensors in biological assays.
4
 
 First developed as a small molecule derivatives of PPEs, 1,4-distyryl-2,5-
arylethynylbenzenes (cruciforms, XFs) were found to exhibit a separation in the frontier 
molecular orbitals (FMOs), allowing for the highest occupied molecular orbital (HOMO) 
and the lowest unoccupied molecular orbital (LUMO) to be independently modified and 
stabilized (or destabilized) in disproportionate amounts, leading to an observable and 
measurable shift in emission wavelength. This unique electronic characteristic has led to 
many advances in utilizing XFs as molecular sensors, and has provided the primary 
motivation for this dissertation. 
 2 
 The initial concept of this work revolved around the synthesis of water soluble 
polymeric materials for use as sensors in biological assays. From the start, the principle 
purpose of this research has been the development of new conjugated architectures with a 
specific focus on how the inclusion of various functionalities would affect not only the 
solubility in organic and aqueous solutions, but most importantly, the electronic 
properties and response upon reaction. Over time, the scope of this research narrowed 
from linear polymeric systems to specifically working with cross-conjugated structures 
and sought to bridge a gap between the knowledge of PPE and cruciform electronics. 
From this work, an explicit question arose that this dissertation has strived to answer: Can 
changes in the electronic properties of polymeric and molecular systems be tuned such 
that a desired change or resulting spectroscopic goal is achieved? It has been shown that 
functionalized materials can react to give a recordable response, but how can we better 
engineer new molecules to maximize specific response while also applying these 
responses into either a device or sensor to be used for practical purposes? 
Overview 
 With the knowledge base presented in this section, a vast array of questions and 
challenges arise regarding the manipulation of cross-conjugated organic materials. 
Systematic analysis and investigation of these problems through a variety of projects is 
discussed herein along with additional related work presented as appendices:  
Chapter 2 
 Chapter 2 details the successful synthesis of a new family of cruciforms: "T"-
shaped materials; these compounds were developed in two classes of compounds, 
 3 
stilbene and distyrylbenzene, with each class mimicking different features of an 
analogous parent 1,4-distyryl-2,5-arylethynylbenzene "X"-shaped cruciform (XF).  
Chapter 3 
 Chapter 3 reports the synthesis and characterization of a new poly(para-
phenyleneethynylene) functionalized with reactive substituents upon the polymer 
backbone for the purposes of carrying out further reactions upon the material. The 
development of polymers for the use of "post-functionalization" reactions is highly 
desirable. Once polymerization is completed, a pure material can be reacted with any 
number of appropriate reagents to generate a new polymer with the desired spectroscopic 
properties (i.e. bathochromically shifted emissions) while also retaining the chain length 
and backbone integrity of the original material. 
Chapter 4 
 Chapter 4 highlights new poly(para-phenyleneethynylene)s for the purposes of 
biosensory applications. Specifically, this chapter focuses on the development of cross-
conjugated PPEs that exhibit bathochromically shifted emissions in aqueous solution. 
Additionally, it was found that these materials can also extract metal-ions from an 
aqueous phase into an organic phase, a quality that is unique among materials of this 
type. 
Chapter 5 
 Chapter 5 reports the development of a fluorophore sensor based on a three 
molecule array and a six solvent system. This sensor was designed for, and successfully 
tested for, the purpose of discrimination and detection of various organic acids. Using 
digital photography and computer software to record color changes in the fluorescent 
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array, a library of known color changes was created, each representing a "finger print" for 
a specific analyte. A blind study of the known library reported 100% accuracy in 
discriminating the compounds (Copyright of the American Chemical Society). 
Chapter 6 
 Chapter 6 reports further refinements of the fluorophore sensor discussed in 
chapter 5. Variations in the molecular array and solvent system were made in the effort to 
discriminate and detect over-the-counter pharmaceuticals. Initial results have shown high 
levels of selectivity between many different types of drugs. 
Chapter 7 
 Chapter 7 focuses on the general conclusions of this dissertation and also provides 
a direction for the future of work in this field of study. 
Appendix A 
 Appendix A details the synthetic development of green fluorescent protein (GPF) 
chromophore derivatives for use as molecular probes. Specifically, these chromophores 
were synthesized (using rational design) as binding ligands for the nuclear receptor 
peroxisome proliferator-activated receptor gamma (PPAR-γ). Initial results are reported 
herein. 
Appendix B 
 Appendix B contains all of the raw numerical values used in the MANOVA 
analysis detailed in Chapter 5. Data was collected in triplicate to best represent the 
average emission color of each photograph. 
Appendix C 
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 Appendix C contains all of the raw numerical values used in the blind test of 
unknown analytes that is detailed in Chapter 5. Data was collected in triplicate to best 
represent the average emission color of each photograph. 
Overview of PPEs and Ratiometric Sensing 
 For a fluorophore to exhibit a ratiometric response, there must be an incongruent 
stabilization/destabilization of the HOMO and LUMO upon reaction of the fluorophore 
with an analyte. The affect on FMOs must also be incongruent - resulting in a net change 
in the band-gap - to produce a color change. This effect is not observed in most organic 
dyes as changes in HOMO/LUMO are often congruent due to similar orbital coefficients.  
 Research in the Bunz group has always had a solid foundation in the investigation 
of poly(para-phenyleneethynylene)s. Linear PPEs are rigid-rod polymers that generally 
fluoresce in the range of 350-600 nm and have found biosensory applications as 










Figure 1.1. PPE binding event. 
 
 In 2002, Wilson and Bunz reported a new derivation of PPEs: cross-conjugated 
'hybrid' polymers that incorporated a PPE backbone and poly(para-phenylenevinylene) 
(PPV) units on the perpendicular axis (Figure 1.2).
8 
With these materials, it was found 
that the electron-donating strength of the PPV units exclusively affected the HOMO. This 
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vital discovery was the beginning of a decade of high-impact research in the Bunz group 
into cross-conjugated materials with disproportionally affected FMOs and also provided 
the original motivation that has led to this dissertation. 
 
Figure 1.2. A) Linear PPE; B) Linear PPV; C) Cross-conjugated hybrid PPV-PPE. 
 
From Polymers to Oligomers: Cruciforms 
 Paralleling our investigation of polymeric systems has been the study of small 
molecule analogs for the PPV-PPE hybrids. The development of 1,4-distyryl-2,5-
bis(arylethynyl)benzenes (cruciforms, XFs) originally began as an endeavor to synthesize 
small molecule analogs of cross-conjugated PPEs.
9
  It was quickly determined that 
donor- and/or acceptor substitution of the XF arms induced a spatial separation of the 
frontier molecular orbitals (FMOs) of these molecules.  This unique effect allowed for the 
tuning of electronic properties based on the relative positions of the HOMO and LUMO 
and generated incongruent effects on both FMOs upon reaction, producing a ratiometric 

























Figure 1.3. Spatially separated frontier molecular orbitals in functionalized cruciforms.
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 Furthermore, it was found that functionalization of both the alkynyl and styryl 
axes permitted the construction of dyes exhibiting a two-stage response.
11
 The example 
shown in figure 1.4 illustrates two distinct binding events upon the addition of increasing 
amounts of zinc (II) triflate to XF2: first, the metal cation binds to the dibutylamino 
groups positioned on the electron rich styryl axis. This binding causes a significant 
stabilization of the HOMO and has little effect on the LUMO, thus generating a net 
increase in the band gap, and a resulting hypsochromic shift in emission from yellow to 
blue. Further addition of the metal cation induces binding to the electron poor pyridyl 
units located on the arylethynyl axis, which stabilizes the LUMO to a much greater extent 
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than the HOMO, resulting in a net decrease in the band gap and a bathochromic shift in 
the emission from blue to green. 
 
 
Figure 1.4. Two-stage fluorescence response upon binding with increasing amounts of zinc (II) triflate.
10 
 
 Having clearly defined the electronic properties of both PPE/PPV hybrids and 
cruciforms, this dissertation seeks to take our current knowledge of these materials and 
apply it in a rational manner for two purposes: 1) synthesizing new materials where we 
can tune the spectroscopic properties for a desired purpose and 2) exploiting the 
ratiometric sensing potential of known materials to design a "chemical nose" sensor 
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CHAPTER 2 





 fluorophores are molecules that are X-shaped
3
 and typically (but not 
always) display a central aromatic hub to which conjugated arms consisting of different 
π-systems are added.
4-7
 Derivatives of this concept lead to molecules of similar shapes 
and topologies that have been termed H-shapes and Z-shapes.
8
 The presence of two axes 
in XFs has dramatic effects on their electronic structure if the axes are donor and 
acceptor-substituted respectively. In such a case, a locally disjoint frontier molecular 
orbital picture emerges. The HOMO is almost completely localized on the more electron 
rich axis of the XF, while the LUMO is localized on the traverse with the electron 
accepting groups. As a consequence, the effect of attachment of electron donors or 
electron accepting substituents to the proper axes of the XF has an amplifying effect on 
their HOMO-LUMO gap and therefore on their absorption and emission maxima.  
Working with dialkylamino and pyridine groups the emission color of the XFs can be 
tuned from blue to orange.  Both pyridine and dialkylamino groups display free electron 
pairs, therefore XFs equipped with such structural elements are also metallochromic and 
acidochromic, and display distinct changes in fluorescence upon protonation or 
metalation. A hitherto not investigated aspect of XFs is the study of the influence of the 
single arms on the overall electronic properties of the XF systems. To generate insight 
into this topic we have created a series of T-shaped fluorophores 1S-5S and 1T-5T and 
investigated their optical and electronic properties and compared them with those of their 
corresponding XFs 1X-5X. The S-series is derived from the X-series by "snipping" off a 
 11 
styryl arm, while the T-series is obtained from the X-series by stripping away an 
aryleneethynylene unit. Doing this improves the understanding the fundamental 
properties of the XFs and might give insight into principles that guide the construction of 
novel fluorophores and chromophores. 
 
Figure 2.1. Examples of cruciform molecules. 
 
Results and Discussion 
Synthesis of T and S Molecules 
 Figure 2.1 shows the structures in the T and S-series that have been prepared and 
compared herein. The synthesis is straightforward and shown in Scheme 1.  For the S-
series we start from 6, which upon partial radical bromination followed by an Arbuzov 
reaction with triethylphosphite gives rise to the isolation of 7.  A Horner reaction with 
any of the aldehydes 8a-d furnishes the styrene derivatives 9a-d in yields from X-Y %.  
A subsequent Sonogashira coupling finishes the sequence to give 1S-5S.  The preparation 
of the T-series proceeds analogously.  Starting from iodoxylene 11, bromination with 
 12 
NBS furnishes phosphonate 12 after Arbuzov-reaction of the intermediate with 
triethylphosphite.  Sonogashira alkynylation 10a-c then furnishes the desired targets 1T-
5T in good-to excellent yields. We did not encounter any difficulties in this synthetic 
scheme of T and D which is slightly modified from that of the synthesis of the published 
compounds 1X-5X. 
 




Figure 2.3. Synthesis of S and T series T-shapes. 
 
Optical and Electronic Properties 
 
The main purpose in the development of these compounds was to serve as a 
comparison to known 1,4-distyryl-2,5-arylethynylbenzenes, hopefully be able to draw 
conclusions on how variations in the conjugated system (i.e., removing an arm or part of 
the electronic system) affected the photophysical properties, and perhaps most 
importantly, the disjointed FMO structure observed in substituted cruciforms. 
As expected from our previous studies with 1,4-distyryl-2,5-arylethynylbenzenes, 
many of the T-shapes exhibited significant solvatochromism over a wide range of non-
polar and polar solvents. In particular, compounds with highly electron donating 
dibutylamino groups generated emissions ranging the gamut of the visible spectrum, 
while neutral and electron-accepting substituted compounds retained similar fluorescence 
in a variety of solvents (figure 2.4). Tables 2.1 and 2.2 detail the optical properties of the 




Figure 2.4. Digital photographs of T-shape emission in 10 different solvents. Photographs were taken 
under a handheld UV light (λmax ex = 365 nm) using a Canon EOS 30D digital camera equipped with a 
Canon EFS 18-55mm zoom lens. 
 
 
Table 2.1. Absorption and emission of 1S-5S in a representative solvent. Quantum yield and fluoroescence 






1S 2S 3S 4S 5S 
λmax Abs 
(nm) 
305 323 323, 364 305 319 
λmax Em 
(nm) 














1T 2T 3T 4T 5T 
λmax Abs 
(nm) 
300, 362 273, 419 268, 412 297, 359 269, 415 
λmax Em 
(nm) 
401, 424 479 455, 485 404, 426 466 
Quantum 
Yield (Φ) 
0.98 0.38 0.44 0.98 0.5 
Fl. Lifetime 
(τ, ns) 










Photostability of Stilbene T-Shapes  
While collecting fluorescence data, it was discovered that the stilbenoid 
compounds exhibited variations in emission upon exposure to ambient light. To 
investigate this problem, a time dependent study was conducted in which the emission of 
a representative stilbene (3S) was recorded over a one hour time period upon exposure to 
various amounts of ultraviolet light (figure 2.5). The initial sample was prepared in 
dichloromethane in a dark room and produced a broad emission at 533 nm with a small 
peak visible at 332 nm. Even after short exposure to light (2 min), the relative intensities 
of the two peaks were nearly equivalent and a new peak at 349 nm was clearly evident. 
The growth of the higher energy peaks drastically increased in intensity as the molecule 
was continually exposed to light over a one hour time frame. 
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Figure 2.5. Emission of 3S upon continual exposure to UV-light (λmax = 365 nm). 
 
Since compounds 1S-5S exhibit these variable emissions in solution, application 
in sensing assays become severely limited and impractical for widespread use.  The 
mechanism for this transition is currently unknown; 
1
H NMR data was inconclusive in 
determining the possibility of a ‘hula-twist’ around the double bond, a characteristic 
previously observed with stilbenes.
9-11
  we chose to withhold further investigations into 
the stilbene compounds as the purposes of our studies were to develop new compounds 
for use as proton and metal detection probes. Conversely, none of the distyryl T-shapes 
demonstrated instability to light, and therefore became a much more attractive structure 
for further examination. This knowledge will also aid in the development of future 
molecular architectures as we begin to gain insight into the stability of different types of 
cross-conjugated materials. 
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Proton and Metal Sensing 
Alterations in spectroscopic properties were investigated in compounds with 
reactive functionalities (Figure 2.6). As expected, no changes in emission were observed 




 to any of the compounds. Additionally, 3T-5T bound Li
+
 
while 2T did not, which was also analogous to previously reported data on 1,4-distyryl-
2,5-arylethynylbenzene models.
12
 The most unexpected results were found in the lack of 
binding of  2T with Mg
2+
 along with the quenching associated with zinc, manganese, 
copper, and trifluoroacetic acid. Reaction of Mg
2+
 to the corresponding pyridyl 
substituted XF had been found to elicit a significant bathochromic shift in the emission,
12
 
whereas the T-shape model exhibited no alterations in fluorescence. Upon reaction with 
the transition metals, the emission was highly red-shifted, but more importantly, the 
relative fluorescence of the bound material was reduced to the point that it appeared 
completely quenched to the naked eye, lending this molecule towards use as a very 
effective turn-off sensor.  
 
 
Figure 2.6. Reaction of 2T-5T with metal triflates and trifluoroacetic acid. All sensing studies were 
performed in dichloromethane at a concentration equivalent to the solubility of each metal salt in the 
solvent. Photographs were taken under a handheld UV light (λmax ex = 365 nm) using a Canon EOS 30D 
digital camera equipped with a Canon EFS 18-55mm zoom lens. 
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Conclusions 
 We have synthesized a new series of cross-conjugated distyryl-
arylethynylbenzene derivatives based on a “T-shape” motif. Incorporation of various 
reactive functionalities impart binding capabilities of various metals in solution, allowing 
for the ratiometric detection of these analytes. It was found that the stilbenoid analogues 
degraded over time upon exposure to ambient light while the distyryl compounds were 
photostable, knowledge that provides a solid foundation for future synthesis of new 
cross-conjugated architectures. Additionally, an effective turn-off sensor was developed 









Work is currently underway to build new libraries of cruciforms with much larger 
conjugated systems containing multiple axes. 
Experimental Procedures 
Materials and Methods 
 
All chemicals and solvents were purchased from commercial sources and were 
used without further purification unless otherwise specified. All IR spectra were obtained 
using a Shimadzu FTIR-8400s spectrometer. 
1
H NMR spectra were recorded at 298 K on 
a 300 MHz spectrometer. Chemical shifts are reported in parts per million (ppm), using 
residual solvent (chloroform-d) as an internal standard.  The data is reported as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, 
br = broad), and integration. 
13
C HMR spectra were recorded at 400 MHz, and 
13
C 
chemical shifts () are referenced to residual CHCl3 at 77.23 ppm or residual DMSO at 
39.5 ppm. All absorption spectra were collected using a Shimadzu UV-2401PC 
spectrophotometer. All emission spectra were acquired using a Shimadzu RF-5301PC 
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spectrofluorophotometer.  Quantum yields for the polymer was measured using standard 
procedures.
13
 In all cases, quinine sulfate and 2-aminopyridine were used as standards 
and all solutions were purged with nitrogen prior to measurement. 
Synthesis and Characterization Data 
 
Figure 2.7. Synthesis of monomer M1. 
 
 A stirred suspension of 1 (35.8 g, 100 mmol), NaBr (11.3 g, 110 mmol) and 30% 
H2O2 (15 mL, 150 mmol) in CH2Cl2 (200 mL) was cooled on an ice bath.  Conc. H2SO4 
(10 mL, 180 mmol) was added dropwise over 5 min.  The ice bath was removed and the 
reaction was irradiated by a tungsten incandescent bulb, whilst vigorous stirring was 
maintained.  After 24 h, irradiation was stopped and the mixture was allowed to cool to 
room temperature.  The solution was washed with dilute Na2SO3 (aq) followed by H2O.  
The organic fraction was dried over MgSO4 and the solvent was evaporated in vacuo.  
The residue after evaporation consisted chiefly of an equimolar mixture of 13 and the 
mono-brominated product.  To this mixture of products, P(OEt)3 (10 g, 60 mmol) was 
added and the suspension was refluxed with stirring for 6h.  After cooling to RT, the 
resulting solid was purified by column chromatography (hexanes to CH2Cl2) followed by 





H-NMR, CDCl3 (δ, 300MHz): 1.26 (t, 6H, J = 6 Hz); 2.31 (d, 3H, J = 3 
Hz); 3.26 (d, 2H, J = 27 Hz); 4.04 (p, 4H, J = 6 Hz); 7.64 (s, 1H); 7.79 (d, 1H, J = 3 Hz).  
13
C-NMR, CDCl3 (δ, 75MHz): 16.7, 27.2, 37.0, 62.6, 100.9, 101.0, 135.0, 140.1, 140.3, 
 20 
142.3.  IR (cm
-1




Figure 2.8. General reaction for the synthesis of diiodostilbene precursors for 1S-5S. 
 
Synthesis of 2a. 
A solution of M1 (3.90g, 7.89 mmol) in dry THF (30 mL) was stirred under N2.  
To this solution, KO
t
Bu (1.40g, 12.5 mmol) was added followed by 4-(1-
methylethyl)benzaldehyde (1.11g, 7.49 mmol).  The solution was stirred for 2h and 
subsequently quenched with MeOH (5 mL).  The solvent was removed in vacuo and the 
residue purified by column chromatography (hexanes).  Stilbene 2a (2.72g, 70% yield) 
was obtained as a colorless solid.  Mp: 74-76
o
C (decomp.).  
1
H-NMR, CDCl3 (δ, 
300MHz): 1.27 (d, 6H, J = 7 Hz); 2.36 (s, 3H); 2.92 (m, 1H, J = 7 Hz); 6.89 (d, 1H, J =  
16 Hz); 7.11 (d, 1H, J = 16 Hz); 7.23 (d, 2H, J = 6 Hz); 7.46 (d, 2H, J = 8 Hz); 7.69 (s, 
1H); 7.99 (s, 1H).  
13
C-NMR, CDCl3 (δ, 75MHz): 24.0, 27.2, 34.0, 99.8, 101.2, 122.2, 
126.9, 126.9, 129.7, 131.8, 134.3, 135.7, 139.8, 139.9, 142.1, 149.2.  IR (cm
-1
): 3035.1, 
3001.3, 2967.6, 2956.0, 2934.8, 2348.4, 1898.0, 1347.3, 1051.2, 854.5. 
Synthesis of 2b. 
A solution of M1 (2.6g, 5.26 mmol) in dry THF (20 mL) was stirred under N2.  
To this, KO
t
Bu (0.71g, 6.33 mmol) was added followed by 4-dibutylaminobenzaldehyde 
(1.18g, 5.06 mmol). The solution was stirred for 2 hours and quenched with H2O.  The 
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mixture was extracted with Et2O, and dried over MgSO4.  An excess of dry HCl in Et2O 
was added; the precipitated solid was recovered via vacuum filtration and recrystallized 
from CHCl3/Et2O.  Compound 2b (1.53g, 48% yield) was obtained as a colorless 
crystalline solid.  Mp: 196-198
o
C (decomp.).  
1
H-NMR, CDCl3 (δ, 300MHz): 0.85 (m, 
6H); 1.27 (m, 6H); 2.01 (m, 2H); 2.37 (s, 3H); 3.33 (m, 4H); 6.90 (d, 1H, J = 16 Hz); 
7.21 (d, 1H,  J = 16 Hz); 7.69 (m, 5H), 7.98 (s, 1H); 13.95 (s, 1H).  
13
C-NMR, CDCl3 (δ, 
75MHz): 13.5, 19.9, 26.6, 27.3, 58.8, 100.0, 101.2, 122.2, 123.1, 128.4, 129.5, 133.2, 
136.0, 137.5, 138.5, 138.8, 139.9, 143.1.  IR (cm
-1
): 3035.1, 2961.8, 2872.1, 2398.6, 
2348.4, 1514.2, 1041.6, 671.3, 602.8. MS (EI): (M
+
) 573.0386 (found); 573.0390 (calc’d 
for C23H29I2N). 
  
Figure 2.9. Synthesis of 1S. 
 
Synthesis of 1S. 
 
 To a degassed solution of M1 (0.30 g, 0.62 mmol) in 30% piperidine/THF (4 
mL), 3a (0.31 g, 3.1 mmol) was added followed by CuI (1 mg, 0.006 mmol) and 
Pd(PPh3)2Cl2 (7 mg, 0.009 mmol).  The solution was allowed to stir overnight under N2.  
The mixture was diluted with H2O, neutralized with AcOH and extracted with hexanes. 
The solvent was evaporated in vacuo, and the residue was purified via column 
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chromatography (hexanes to 8% CH2Cl2/Hexanes) followed by recrystallization from 
EtOAc/MeOH at -10
o
C.  Compound 1S (0.20g, 75% yield) was obtained as a colorless 




H-NMR, CDCl3 (δ, 300MHz): 1.27 (d, 6H, J = 7 
Hz); 2.51 (s, 3H); 2.93 (m, 1H, J = 7 Hz); 7.24 (m, 3H); 7.39 (m, 7H); 7.51 (m, 2H, J = 8 
Hz); 7.59 (m, 5H); 7.86 (s, 1H).  
13
C-NMR, CDCl3 (δ, 75MHz): 14.7, 20.3, 24.0, 34.0, 
88.0, 88.1, 94.7, 95.4, 121.8, 122.2, 123.3, 123.5, 124.9, 126.7, 126.9, 128.0, 128.4, 
128.5, 130.0, 131.5, 131.6, 133.4, 135.0, 136.5, 138.7, 148.8.  IR (cm
-1
): 3051.5, 2955.0, 
2863.4, 2357.1, 1504.5, 1439.9, 959.6, 751.3, 690.5.  MS (EI): (M
+
) 436.2194 (found); 




Figure 2.10. Synthesis of 2S. 
 
Synthesis of 2S. 
To a solution of 3b (0.62 g, 1.3 mmol) in 30% piperidine/THF (3.5 mL), 
TBAF•3H2O (1.60 g, 5.08 mmol) was added.  The solution was allowed to stir under N2 
for 5 min and 2a (0.82 g, 3.17 mmol) was added followed by CuI (3 mg, 0.01 mmol) and 
Pd(PPh3)2Cl2 (14 mg, 0.020 mmol).  The mixture was allowed to stir overnight under N2, 
H2O was added and the mixture was extracted with Et2O.  The extracts were dried over 
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NaOH pellets and evaporated in vacuo.  The residue was purified via column 
chromatography (hexanes to 25% EtOAc/hexanes) followed by recrystallization from pet. 
ether (-78
o
C).  Compound 4 (0.13 g, 23% yield) was obtained as a dark yellow crystalline 
solid.  Mp: 150-151
o
C (decomp.).  
1
H-NMR, CDCl3 (δ, 300MHz): 1.47 (d, 6H, J = 8 Hz); 
2.51 (s, 1H); 2.94 (m, 1H, J = 8 Hz); 7.25 (m, 3H); 7.48 (m, 8H); 7.87 (s, 1H); 8.64 (m, 
4H).  
13
C-NMR, CDCl3 (δ, 75MHz):  20.2, 23.9, 34.0, 92.1, 92.2, 92.3, 92.8, 121.3, 
123.2, 124.2, 125.4, 125.5, 126.7, 127.0, 128.5, 131.0, 131.2, 133.8, 134.6, 137.1, 139.1, 
149.3, 149.9.  IR (cm
-1
): 3040.9, 3023.5, 2966.6, 2865.4, 2385.1, 2223.0, 2206.6, 1537.3, 
1514.2, 1496.8, 1406.2, 819.8.  MS (EI): (M
+
) 438.2099 (found); 438.2096 (calc’d for 
C32H26N2). 
 
Figure 2.11. Synthesis of 3S. 
Synthesis of 3S 
A degassed solution of 2b (0.45 g, 0.74 mmol) in 50% piperidine/THF (5 mL) 
was stirred under N2.  To this solution, CuI (2 mg, 0.008 mmol) and Pd(PPh3)2Cl2 (8 mg, 
0.01 mmol) were added, followed by 3a (0.40 g, 3.9 mmol).  The solution was stirred 
overnight, and water was added. The mixture was extracted with Et2O, dried over NaOH 
pellets, and the solvent was evaporated in vacuo.  The residue was purified via column 
chromatography (hexanes to 1:5:94 TEA/CH2Cl2/Hexanes) providing an oil.  The oil was 
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crystallized from petroleum ether at -78
o
C to provide 3S (0.22 g, 49% yield) as a yellow 
solid.  Mp: 40-42
o
C (decomp.).  
1
H-NMR, CDCl3 (δ, 300MHz): 0.95 (t, 6H, J = 7 Hz); 
1.43 (m, 4H, J = 7 Hz); 1.56 (m, 4H, J = 7 Hz); 2.48 (s, 3H); 3.28 (t, 4H, J = 7 Hz); 6.62 
(d, 2H, J = 9 Hz); 7.14 (d, 1H, J = 16 Hz); 7.37 (m, 10H); 7.57 (m, 4H); 7.82 (s, 1H).  
13
C-NMR, CDCl3 (δ, 75MHz): 14.1, 14.7, 20.4, 29.5, 50.8, 88.4, 88.5, 94.4, 95.1, 111.6, 
120.6, 121.1, 122.2, 123.3, 123.4, 123.5, 124.5, 127.5, 128.1, 128.3, 128.4, 128.5, 130.4, 
131.5, 131.6, 133.3, 137.4, 137.7, 148.0.  IR (cm
-1
): 3031.2, 2954.1, 2869.2, 2201.8, 
1605.8, 1597.1, 1515.1, 1366.6, 1183.4, 958.7, 688.6.  MS (EI): (M
+
) 521.3085 (found); 




Figure 2.12. Synthesis of 4S. 
 
Synthesis of 4S 
A 20% (m/v) KOH/MeOH solution (3 mL) was cooled on an ice bath and 2b 
(0.50 g, 0.82 mmol) was added followed by 3c (0.56 g, 2.5 mmol). The solution was 
cooled for 5 min with periodic shaking and then added to a solution of 50% 
piperidine/THF (10 mL).  The mixture was allowed to stir for 3 minutes under N2 at 
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which point, CuI (2 mg, 0.008 mmol) and Pd(PPh3)2Cl2 (8 mg, 0.01 mmol) were added.  
The mixture was stirred overnight under N2 at 40
o
C.  Next, dilute NH3 (aq) was added 
and the mixture was extracted with Et2O.  The extract was dried over Na2SO4 and the 
solvent removed under reduced pressure.  The residue was purified by column 
chromatography (30% CH2Cl2/hexanes) followed by recrystallization from pet. ether at -
78
o





H-NMR, CDCl3 (δ, 300MHz): 0.97 (t, 6H, J = 7 Hz); 1.38 (m, 4H, J = 7 
Hz); 1.59 (m, 4H, J = 7 Hz); 2.51 (s, 3H); 3.31 (t, 4H, J = 7 Hz); 6.65 (d, 2H, J = 9 Hz); 
7.15 (d, 1H, J = 16 Hz); 7.35 (d, 1H, J = 16 Hz); 7.43 (m, 3H); 7.82 (m, 3H); 7.99 (m, 
4H, J = 4 Hz).  
13
C-NMR, CDCl3 (δ, 75MHz): 14.0, 14.7, 20.3, 29.4, 50.8, 91.5, 91.7, 
92.4, 111.6, 119.6, 120.5, 121.2, 121.7, 122.2, 122.3 123.0, 123.9, 124.8, 125.6, 125.7, 
128.0, 128.1, 131.3, 131.8, 132.3, 132.7, 133.5, 137.9, 138.2, 148.3.  IR (cm
-1
): 2962.8, 
2936.7, 2931.9, 2876.0, 2207.6, 1604.8, 1523.8, 1370.5, 1275.0, 1171.8, 1106.2.  MS 
(EI): (M
+
) 793.2571 (found); 793.2578 (calc’d for C43H35F12N). 
 
 
Figure 2.13. Synthesis of 5S. 
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Synthesis of 5S. 
A solution of 2b (0.45 g, 0.74 mmol) in 50% piperidine/THF (3.5 mL) was stirred 
under N2 and TBAF•3H2O (2.5 g, 7.9 mmol) was added.  The solution was heated to 
40
o
C and 3b (0.48 g, 1.85 mmol) was added, followed by CuI (2 mg, 0.008 mmol) and 
Pd(PPh3)2Cl2 (8 mg, 0.01 mmol).  The mixture was stirred under nitrogen for 2 days at 
40
o
C, after which, brine was added.  The mixture was extracted with Et2O and washed 
with dilute NH3(aq).  The organic phase was dried over NaOH pellets and the solvent was 
removed under reduced pressure.  The residue was purified by column chromatography 
(1:49:50 TEA/EtOAc/Hexanes) which provided 5S (0.17 g, 44% yield) as a red/orange 
waxy solid.  
1
H-NMR, CDCl3 (δ, 300MHz): 0.95 (t, 6H, J = 6 Hz); 1.35 (m, 4H, J = 6 
Hz); 1.58 (m, 4H, J = 6 Hz); 2.46 (s, 3H); 3.28 (t, 4H, J = 6 Hz); 6.62 (d, 2H, J = 9 Hz); 
7.13 (d, 1H, J = 16 Hz); 7.31 (d, 1H, J = 16 Hz); 7.40 (m, 7H); 7.83 (s, 1H); 8.62 (m, 
4H).  
13
C-NMR, CDCl3 (δ, 75MHz): 14.0, 20.0, 20.3, 29.5, 50.7, 91.9, 92.6, 92.7, 92.8, 
111.8, 119.8, 120.7, 123.1, 124.2, 125.4, 128.1, 131.3, 131.4, 133.7, 137.9 138.1, 148.4, 
149.8.  IR (cm
-1
): 3026.4, 2953.1, 2943.5, 2924.2, 2867.3, 2859.6, 2435.2, 2201.8, 
1591.3, 1515.1, 817.9.  MS (EI): (M
+




Figure 2.14. Synthesis of 1T 
 
Synthesis of 1T. 
 To a degassed solution of 4a (0.60 g, 1.2 mmol) in 33% piperidine/THF (7 mL), 
CuI (5 mg, 0.02 mmol) and Pd(PPh3)2Cl2 (30 mg, 0.043 mmol) were added, followed by 
3a (0.25 g, 2.44 mmol).  The solution was stirred overnight under N2 and poured into 
H2O.  The mixture was extracted with Et2O and dried over Na2SO4.  The solvent was 
evaporated in vacuo and the residue was purified by column chromatography (hexanes to 




H-NMR, CDCl3 (δ, 300MHz): 1.26 (d, 12H, J = 7 Hz); 2.91 (m, 2H, J = 7 Hz); 7.02 (d, 
1H, J = 16 Hz); 7.13 (d, 1H, J = 16 Hz); 7.22 (m, 5H); 7.44 (m, 8H); 7.60 (m, 2H); 7.68 
(m, 3H).  
13
C-NMR, CDCl3 (δ, 75MHz): 23.9, 33.9, 88.1, 94.3, 122.4, 123.5, 125.0, 
125.7, 126.5, 126.6, 126.7, 126.7, 126.8, 126.8, 128.3, 128.4, 129.2, 130.0, 130.6, 131.6, 
134.9, 135.2, 136.5, 137.9, 148.7, 148.8.  IR (cm
-1
): 3047.6, 3022.6, 2956.0, 2361.0, 
2331.1, 1513.2, 1492.0, 967.3, 755.2.  MS (EI): (M
+
) 466.2654 (found); 466.2661 (calc’d 




Figure 2.14. Synthesis of 2T. 
 
Synthesis of 2T 
A degassed solution of 3b (0.30 g, 1.1 mmol) and TBAF•3H2O (0.50 g, 1.6 
mmol) in 30% piperidine/THF (4 mL) was stirred for 5 min under N2; 4b (0.45 g, 0.91 
mmol) was added, followed by Pd(PPh3)2Cl2 (10 mg, 0.014 mmol) and CuI (2 mg, 0.009 
mmol).  The solution was stirred overnight at 40
o
C and poured into dilute NH3 (aq).  The 
mixture was extracted with Et2O, and the extracts were dried over NaOH pellets.  The 
solvent was removed in vacuo and the residue was purified column chromatography 
(30% CH2Cl2/Hexanes to CH2Cl2) followed recrystallization from pet. ether at -78
o
C, 





H-NMR, CDCl3 (δ, 300MHz): 1.28 (d, 12H, J = 7 Hz); 2.93 (m, 2H, J = 7 
Hz); 7.03 (d, 1H, J = 17 Hz); 7.15 (d, 1H, J = 17 Hz); 7.25 (m, 5H); 7.48 (m, 7H); 7.61 
(d, 1H, J = 17 Hz); 7.72 (m, 2H); 8.72 (m, 2H).  
13
C-NMR, CDCl3 (δ, 75MHz): 23.8, 
33.9, 34.0, 91.4, 92.7, 121.1, 125.1, 126.3, 126.6, 126.7, 126.8, 126.9, 127.4, 129.5, 
130.6, 130.8, 134.7, 134.9, 136.6, 138.3, 148.9, 149.1, 149.8.  IR (cm
-1
): 3022.6, 2957.0, 
 29 
2869.2, 2348.4, 2209.5, 1592.3, 1513.2, 966.4, 830.4, 815.0.  MS (EI): (M
+
) 467.2614 
(found); 467.2613 (calc’d for C35H33N). 
 
Figure 2.16. Synthesis of 3T. 
 
Synthesis of 3T. 
To a degassed mixture of 4b (0.71g, 1.1 mmol) in 50% piperidine/THF (6 mL), 
3b (0.49 g, 4.3 mmol) was added under N2. Next, CuI (4 mg, 0.02 mmol) and 
Pd(PPh3)2Cl2 (26 mg, 0.037 mmol) were added and the mixture was stirred overnight at 
40
o
C.  The mixture was poured into brine and extracted with Et2O.  The extracts were 
dried over NaOH pellets, and the solvent was evaporated in vacuo.  The residue was 
purified via column chromatography (hexanes to 20% CH2Cl2/hexanes), providing 3T 
(0.44g, yield 65%) as an orange oil.  
1
H-NMR, CDCl3 (δ, 300MHz):  0.95 (t, 12H, J = 7 
Hz); 1.35 (m, 8H, J = 8 Hz); 1.57 (m, 8H, J1 = 8 Hz, J2 = 7 Hz); 3.28 (t, 8H, J = 7 Hz); 
6.61 (d, 2H, J = 9 Hz); 6.62 (d, 2H, J = 9 Hz); 6.81 (d, 1H, J = 16 Hz); 7.03 (d, 1H, J = 
16 Hz); 7.12 (d, 1H, J = 16 Hz); 7.38 (m, 8H); 7.48 (d, 1H, J = 16 Hz); 7.61 (m, 4H).  
13
C-NMR, CDCl3 (δ, 75MHz): 14.3, 20.6, 29.7, 51.1, 88.9, 93.9, 111.8, 111.9, 121.6, 
121.7, 122.8, 124.0, 124.5, 124.7, 125.0, 126.3, 128.1, 128.2, 128.4, 128.6, 129.1, 130.0, 
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130.3, 131.8, 136.6, 138.1, 148.1, 148.2.  IR (cm
-1
): 3032.2, 2955.0, 2894.3, 2348.4, 
1601.0, 1519.0, 1360.8, 1185.3, 957.7.  MS (EI): (M
+
) 636.4425 (found); 636.4444 (calcd 
for C46H56N2). 
 
Figure 2.17. Synthesis of 4T. 
 
Synthesis of 4T 
A solution of 3c (0.49 g, 1.6 mmol) in 10% KOH/MeOH (5 mL) was shaken 
periodically over 10 min.  This solution was added to a degassed mixture of 4b (0.75 g, 
1.1 mmol) in 50% piperidine/THF (6 mL) under N2. To this, CuI (2 mg, 0.01 mmol) was 
added, followed by Pd(PPh3)2Cl2 (12 mg, 0.017 mmol), and the mixture was stirred 
overnight. The mixture was poured into water and extracted with Et2O. The extracts were 
dried over Na2SO4, and the solvent was evaporated in vacuo. The residue was purified by 
column chromatography (15% CH2Cl2 / hexanes) followed by crystallization from 





H-NMR, CDCl3 (δ, 300MHz): 0.96 (t, 12H, J = 7 Hz); 
1.33 (m, 8H, J = 7 Hz); 1.58 (m, 8H, J = 7 Hz); 3.29 (t, 8H, J = 7 Hz); 6.62 (d, 2H, J = 9 
Hz); 6.64 (d, 2H, J = 9 Hz); 6.82 (d, 1H, J = 16 Hz); 7.05 (d, 1H, J = 16 Hz); 7.13 (d, 1H, 
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J = 16 Hz); 7.41 (m, 6H); 7.63 (d, 1H, J = 8 Hz); 7.64 (d, 1H, J = 16 Hz); 7.82 (s, 1H); 
8.01 (s, 2H).  
13
C-NMR, CDCl3 (δ, 75MHz): 13.8, 13.9, 20.3, 20.4, 29.5, 29.6, 50.8, 90.6, 
92.6, 111.8, 120.0, 121.0, 121.3, 122.3, 124.4, 124.5, 124.6, 124.9, 126.2, 127.0, 127.9, 
128.0, 129.4, 130.0, 130.5, 131.3, 131.4, 131.8, 132.3, 132.7, 136.6, 138.4, 148.1, 148.3.  
IR (cm
-1
): 3093.0, 2956.0, 2872.1, 2388.0, 2209.0, 1601.0, 1519.0, 1185.3, 893.1.  MS 
(EI): (M
+
) 772.4164 (found); 772.4191 (calc’d for C48H54F6N2).  Anal. Found (calc’d for 
C48H54F6N2): C 74.35% (74.59%), H 7.15% (7.04%). 
 
Figure 2.18. Synthesis of 5T. 
 
Synthesis of 5T 
 To a solution of 10% KOH/MeOH (4 mL) at -10
o
C, 4b (0.70 g, 4.0 mmol) was 
added and the solution was cooled in the dark for 20 min.  This was added to a degassed 
solution of 3b (0.60 g, 1.2 mmol), CuI (7 mg, 0.04 mmol) and Pd(PPh3)2Cl2 (16 mg, 
0.022 mmol) in of 50% TEA/THF (7 ml) under N2.  The reaction mixture was stirred 
overnight, and filtered through 50 mL of silica (10% MeOH/EtOAc).  The filtrate was 
concentrated in vacuo, dissolved into 50% Et2O/CHCl3 and titrated with anhy. HCl in 
Et2O until salt ceased precipitating.  The supernatant was washed with dilute K2CO3 (aq) 
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and concentrated in vacuo, providing a red oil. The residue was purified by column 
chromatography (30% CH2Cl2/Hexanes to 2% TEA/CH2Cl2) providing 5T (0.25 g, 38% 
yield) as an orange oil. 
1
H-NMR, CDCl3 (δ, 300MHz): 0.95 (t, 12H, J = 7 Hz); 1.35 (m, 
8H, J = 8 Hz); 1.57 (m, 8H, J = 8 Hz); 3.28 (t, 8H, J = 8 Hz); 6.62 (m, 4H); 6.81 (d, 1H, J 
= 16 Hz); 7.04 (d, 1H, J = 16 Hz); 7.12 (d, 1H, J = 16 Hz); 7.39 (m, 8H); 7.62 (d, 1H, J = 
7 Hz); 7.63 (d, 1H, J = 16 Hz); 8.62 (d, 2H, J = 6 Hz).  
13
C-NMR, CDCl3 (δ, 75MHz): 
14.1, 20.4, 29.5, 50.8, 90.9, 93.5, 111.6, 111.7, 120.2, 120.8, 122.2, 124.3, 124.4, 124.5, 
125.5, 127.0, 127.9, 128.1, 129.2, 130.2, 130.4, 131.8, 136.5, 138.3, 148.0, 148.1, 149.9.  
IR (cm
-1
): 3033.2, 2955.0, 2868.2, 2384.1, 2204.7, 1601.9, 1519.0, 1185.3, 818.8.  MS 
(EI): (M
+
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SUBSTITUTED POLY(PARA-PHENYLENEETHYNYLENE)S TO 




 The concept of post-functionalizing materials is one that many groups have 
investigated in recent years, with simplification of synthesis being at the forefront of this 
research.
1-3
 Specifically, convergent methodologies, routes leading to the least number of 
intermediates with minimal purification are vital to combinatorial techniques or the 
synthesis of multiple targets from a few starting materials. With the classical and 







 convergent methodologies are often difficult to pursue, 
as many polymers are synthesized from two different starting materials requiring 
individual synthesis and purification (Figure 3.1). 
 
Figure 3.1. General reaction conditions for Sonogashira cross-coupling polymerizations. 
 
 Recent developments in the Bunz group have extended the concept of post-
functionalization into the world of polymerizations, designing a new methodology for 










 While similar HB polymers have been reported,
8-9
 our group's primary focus has 
been the manipulation and tuning of electronic properties through post-polymerization 





 to produce a variety of HB PPEs, our focus 
shifted to applying these techniques to linear materials (Figure 3.3). 
 36 
 
Figure 3.3. Post-functionalization reaction of linear poly(para-phenyleneethynylene)s. 
 
Results and Discussion 
 
 The overriding purpose of this work was to first prepare a polymer backbone 
upon which further reactions could be performed to yield a material with desired set of 




Figure 3.4. Synthesis of PPE P1. 
 
 Monomer M1 was synthesized via Sonogashira coupling of TMS-acetylene with 
the previously reported diiodide analogue,
12
 while M2 was synthesized according to 
literature procedures.
13
 Synthesis of material P1 provided a basic polymer core from 
which hybrid PPE-poly(para-phenylenevinylene) (PPV) materials could be subsequently 
prepared via Horner-Emmons-Wadsworth reaction of the phosphonate moieties with any 
 37 
convenient aromatic aldehyde. Prior to any post-functionalization, P1 exhibited bright 
blue fluorescence in the solid state, dichloromethane (DCM), and tetrahydrofuran (THF). 
We have previously reported the practicality of preparing cross-conjugated PPE-PPV 
materials, as the inclusion of styryl units on a PPE backbone, especially those substituted 
with highly electron donating/electron accepting units, leads to a bathochromic shift in 
emission wavelength.
12
 To this end, one could envision easily preparing a PPE-PPV with 
a specific emission wavelength by simply taking a pre-made polymer, adding a known 
aldehyde, and subsequently precipitating the material upon coupling. The Horner reaction 
has no effect upon the backbone of the material, a facet of these reactions that drastically 
simplifies any purification techniques; theoretically, the reaction progress could be 
simply monitored by recording the emission at time intervals, and noting when the initial 
fluorescence peak has completely disappeared. 
 For the initial experiments, this project was approached from the standpoint of 
preparing an identical material using two methodologies and comparing the resultant 
emissions: 1) Post-functionalization of a precursor polymer and 2) classical cross-
coupling polymerization (Figure 3.5.). 
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Figure 3.5. Two synthetic approaches: Method 1) Post-functionalization of P1 to yield P2A; Method 2) 
Preparation of P2B under modified Sonogashira cross-coupling conditions. 
 
 The resulting data qualitatively illustrated that is was feasible to post-
functionalize the backbone of a PPE to achieve results similar to the classical synthetic 
approach. As seen in Table 3.1, photographs of the fluorescence recorded under 
blacklight, there is a significant bathochromic shift upon reaction of P1 with 
diethylaminobenzaldehyde (P2A), indicating that a reaction has taken place, and 
additionally, the emission is nearly identical to that of the classically prepared polymer 
(P2B). After precipitation of P2A into hexanes and subsequent dissolution into DCM, 
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addition of trifluoroacetic acid afforded a hypsochromic shift in emission that is 
characteristic of amine protonation in similar systems.
13 
Table 3.1. Emission of P1, P2A, P2B, and P2A + TFA in dichloromethane.  Photographs were recorded 
under a handheld UV light (λmax ex = 365 nm) using a Canon EOS 30D digital camera equipped with a 




 Having qualitatively shown a proof-of-concept, we sought to manually tune the 
emission by reacting aldehydes with neutral, electron donating, and electronic accepting 
properties (Figure 3.6). For these studies, it was imperative to record the spectroscopic 
data (Figure 3.7) in addition to qualitatively examining the emission color via 
photographs (Table 3.2) for the purposes of building a library where a specific aldehyde 
can be associated with a known emission wavelength. 
 
 40 




Figure 3.7. Normalized emission spectra of precursor polymer P1 and post-functionalized products P3-P6. 
 
Table 3.2. Emission of P1, P3, P4, P5, and P6 in tetrahydrofuran.  Photographs were recorded under a 
handheld UV light (λmax ex = 365 nm) using a Canon EOS 30D digital camera equipped with a Canon EFS 




 In all cases, clear distinction in the spectroscopic data was made between 
unreacted P1 and the post-functionalized materials P3-P6, with P6 exhibiting a 
bathochromic shift of over 130 nm upon inclusion of the highly donating dibutylamino 
functionality on the bis-styryl axis. In reference to reaction progression, it was noted that 
in the formation of P6 had not progressed to completion based on characteristic peak at 
 41 
425 nm that is associated with the phosphonate substituted PPE. For the purposes of these 
experiments, further reaction was not undertaken, as the goal of achieving significant red-
shifted emissions were obtained.  
Conclusions and Future Work 
 This chapter has described the successful synthesis of a linear polymer and 
subsequent post-functionalization of the polymer backbone to induce significant 
bathochromic shifts in the emission. Reaction of the pre-cursor PPE with dibutylamino 
benzaldehyde generated a material exhibiting orange fluorescence, with an overall red-
shift of 136 nm; all other aldehydes used in these experiments yielded smaller red-shifts 
in the emission maxima, ranging from 25-42 nm. While we have demonstrated the 
viability of utilizing post-functionalization reactions with polymers, we have yet to 
achieve post-functionalized emission maxima that span the entire visible spectrum. Based 
on the results of P6, the goal of filling in the “missing” colors will likely be dependent on 
the electron donating strength of the corresponding aldehyde; our group is currently 
pursuing these reactions in the hopes of presenting a system where any desired color can 
be achieved through the convenient methodology described in this work. 
Experimental Procedures 
Materials and Methods 
All chemicals and solvents were purchased from commercial sources and were 
used without further purification unless otherwise specified. 
1
H NMR spectra were 
recorded at 298 K on a 300 MHz spectrometer. Chemical shifts are reported in parts per 
million (ppm), using residual solvent (chloroform-d) as an internal standard.  The data is 
reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = 
 42 
quartet, m = multiplet,  br = broad), and integration. All emission spectra were acquired 
using a Shimadzu RF-5301PC spectrofluorophotometer. 
Synthesis and Characterization Data 
 Monomer M1 has been previously prepared within our lab
14
 and M2 was 




Figure 3.8. Synthesis of pre-cursor polymer P1. 
 
Synthesis of P1 
 
 Monomer M1 (300 mg, 7.04 x 10
-4
 mol) was combined with monomer M2 (390 
mg, 7.04 x 10
-4
 mol) in a 25 mL Schlenk tube with 2 mL THF, 1 mL DCM and 1.5 mL 
piperidine. The solution was freeze-pump-thawed three times, followed by addition of 
(PPh3)2PdCl2 (0.49 mg, 0.1 mol %) and CuI (0.27 mg, 0.2 mol %) under a nitrogen 
atmosphere. The reaction was allowed to stir at 35
 o
C for 48 hrs, at which time the 
material was precipitated into a large volume of hexanes. Three subsequent dissolutions 
and precipitations yielded a green solid material in 29.4% yield (150 mg). 
1
H NMR (300 
MHz, CDCl3): δ 7.63 (s, 2H), δ 7.38 (s, 2H), δ 4.10 (t, 8H), δ 3.45 (br-m, 2H), δ 2.74 (br-




Figure 3.9. Synthesis of P3. 
 
Synthesis of P3 
 
 Compound P1 (10 mg, 1.34 x 10
-5 
mol) and 4-pyridinecarboxaldehyde (0.033 mL, 
26 mol eq) were dissolved in 2 mL THF under nitrogen. Once dissolved, potassium tert-
butoxide (39 mg, 26 mol eq.) was added to the mixture, which was allowed to stir for 24 
hours, at which time the resulting material was precipitated in methanol, yielding a 
yellow solid exhibiting λmax em = 451 nm.  
 
 
Figure 3.10. Synthesis of P4. 
 
Synthesis of P4 
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 Compound P1 (10 mg, 1.34 x 10
-5 
mol) and 4-butoxybenaldehyde (0.056 mL, 26 
mol eq) was dissolved in 2 mL THF under nitrogen. Once dissolved, potassium tert-
butoxide (39 mg, 26 mol eq.) was added to the mixture, which was allowed to stir for 24 
hours, at which time the resulting material was precipitated in methanol, yielding a green 
solid exhibiting λmax em = 469 nm. 
 
Figure 3.11. Synthesis of P5 
 
Synthesis of P5 
 
 Compound P1 (10 mg, 1.34 x 10
-5 
mol) and 1-naphthylcarboxaldehyde (55 mg, 26 
mol eq) were dissolved in 2 mL THF under nitrogen. Once dissolved, potassium tert-
butoxide (39 mg, 26 mol eq.) was added to the mixture, which was allowed to stir for 24 
hours, at which time the resulting material was precipitated in methanol, yielding a green 
solid exhibiting λmax em = 461 nm. 
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Figure 3.12. Synthesis of P6. 
 
Synthesis of P6 
 
 Compound P1 (10 mg, 1.34 x 10
-5 
mol) and 4-(N,N dibutyl)aminobenzaldehyde 
(81 mg, 26 mol eq) was dissolved in 2 mL THF under nitrogen. Once dissolved, 
potassium tert-butoxide (39 mg, 26 mol eq.) was added to the mixture, which was 
allowed to stir for 24 hours, at which time the resulting material was precipitated in 
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CHAPTER 4 
RESPONSIVE POLY(PARA-PHENYLENEETHYNYLENE)S WITH 





 are stable and display attractive optical 









Ionically-functionalized PPEs selectively can associate with cellular structures 
via multivalent interactions, making them potentially useful as stains/dyes for 
microscopy.
7
  The utility of PPEs in fluorescence detection can be expanded if PPEs are 
interfaced with a recognition element to form a functional construct.  Here, the 
fluorescence of the PPE serves as a transducer while the other construct component 





 constructs to identify and quantify inorganic and biological analytes 
including bacteria and proteins.
10 
 PPEs typically possess vibrant blue/blue-green emissions in solution not ideal for 
use in biosensing; the background fluorescence of biological samples limits the efficacy 
of PPEs in these applications.  The performance of PPEs in biosensory applications could 
be improved by designing PPEs with lower energy emissions in solution.  Though 
potential useful, few examples water soluble PPEs emitting at longer wavelengths have 




 The introduction of cross-conjugated motifs into PPEs provides an opportunity to 
engineer the bandgap of PPEs.
12
 In the case of PPE-PPV hybrid polymers such as 1, the 
electronic substitution of the styryl axis exclusively affects either the level of the HOMO 
or LUMO.  Introduction of electron donors on the styryl axis results in PPEs exhibiting 
longer wavelength emissions through lifting, i.e. destabilization of the HOMO.  The 
incorporation of swallowtail (e.g. branched oligoethylene glycols) side chains in PPEs 
conveys omniphilic solubility (including water) and helps preserve functional quantum 
yields in highly polar solvents (Figure 4.1).
13 
 
Figure 4.1. Cross conjugated PPEs. 
 
Results and Discussion 
 To examine the potential of this approach we synthesized PPE 2, an alternating 
copolymer containing swallowtail chains as well as donor-functionalized styryl 
sidechains (Figure 4.2). 
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Figure 4.2. Synthesis of PPEs 1 and 2. 
 
 The requisite distyryl monomer 5 was prepared from bisphosphonate 3.
14
  A 
Horner olefination
15
 with para-(diethylamino)benzaldehyde yields 4; subsequent 
Sonogashira coupling
16
 furnishes the TMS-protected monomer 5 as a brilliant orange 
solid, which was deprotected in situ using KOH and polymerized with swallowtail 
monomer 6 using a modified Sonogashira protocol, yielding PPE 2 in 69 % yield (Mn = 
1.7 x 10
4
, Mw/Mn = 1.5). The fluoresence of 2 in six different solvents (with and without 
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the inclusion of acid) is represented in figure 4.3, while the full set of photophysical 
properties are outlined in table 4.1 for PPEs 1 and 2. 
 
Figure 4.3. Emission of 2 (solid traces) and 2H
+
 (dotted traces) in diethyl ether (dark blue trace), CHCl3 
(blue trace), CH3CN (green trace), MeOH (yellow trace), DMSO (orange trace), and H2O (red trace). 
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 Table 4.1. Photophysical properties of 1, 1H
+












 λmax Abs (nm) 395 344 404 346 
λmax Em (nm) 524 444 530 456 
Quantum Yield (Φ) 0.22 0.14 0.17 -
a
 





 λmax Abs (nm) 385 343 408 357 
λmax Em (nm) 538 445 556 462 
Quantum Yield (Φ) 0.20 0.35 0.08 0.30 






 λmax Abs (nm) 402 352 411 356 
λmax Em (nm) 569 441 570 467 
Quantum Yield (Φ) 6.3 x 10
-4
 0.34 0.004 0.26 





 λmax Abs (nm) 387 351 419 363 
λmax Em (nm) 567 442 575 471 




 0.003 0.005 




 λmax Abs (nm) 417 352 410 351 
λmax Em (nm) 566 431 570 466 
Quantum Yield (Φ) -
b
 0.024 0.017 0.045 





λmax Abs (nm) - - 417 351 
λmax Em (nm) - - 583 489 
Quantum Yield (Φ) - - 0.001 0.05 
Fluorescence Lifetime (τ, ns) - - 0.5 2.4 




 PPE 1 is moderately soluble in ether, chloroform, and acetonitrile but precipitates 
from methanol (Figure 4.4). Incorporation of swallowtail side-chains allows for 
dissolution of 2 in solvents ranging from ether to methanol. 
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Figure 4.4. Emission of 1, 1H
+
, 2, and 2H
+
 in a range of solvents.  Vials were photographed under a 
handheld UV light (λmax ex = 365 nm) using a Canon EOS 30D digital camera equipped with a Canon EFS 
18-55mm zoom lens.  Photograph exposure times were varied for each solution to produce images 
reflecting the color of emission. 
 
 In diethyl ether, 1 exhibits a broad absorption (λmax = 395 nm) and broad green 
emission (λmax = 524 nm).  Significant positive solvatochromism is observed in the 
emission of 1 (from 524 nm in ether to 566 nm in methanol); however, the effect is less 
pronounced in the absorption (395 nm → 417 nm).  Upon moving to CHCl3, we observe 
a small blue shift in absorption to 385 nm and a redshift in emission to 538 nm.  As 
solvent polarity increases further, both absorption and emission become more 
bathochromically shifted; in methanol, 1 possesses a broad absorption centered at 417 nm 
and a broad yellow emission at 566 nm. 
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 The absorption and emission of 2 are redshifted relative to 1, which can be 
attributed to the electron donating character of the alkyoxy-substitution in 2 compared to 
the alkyl-substituted 1. In ether, 2 exhibits a broad emission at 404 nm and a featureless 
green emission at 530 nm.  As in 1, significant positive solvatochromism is observed in 
the emission of 2 (from 530 nm in ether to 583 nm in water); similarly, the effect in 
absorption is minimal (404 nm → 417 nm).  This trend remains constant when 
transitioning into more polar solvents.  
 As predicted, addition of TFA to 1 and 2 leads to shifts in both absorption and 
emission in all solvents, with no evidence of significant solvatochromism. Substitution of 
the styryl axis exclusively affects the level of the HOMO, suggesting localization of the 
PPE’s HOMO on the styryl sidechains.  As a result, protonation of the alkylanilines in 1 
and 2 disproportionately stabilizes the HOMO relative to the LUMO, increasing the FMO 
gap and eliciting a spectroscopic blueshift.  
 We also determined the fluorescence quantum yields of 1, 1H
+
, 2, and 2H
+
 in a 
range of solvents.  Generally, as the polarity of the solvent increases, the quantum yield 
decreases, in qualitative accordance with the energy gap law.
17
 Similarly, the spectral 
blueshifts induced by protonation of 1 and 2 are generally accompanied by considerable 
increase in quantum yield.  In less polar solvents including diethyl ether and CHCl3, 1 
possesses a higher quantum yield than 2.  This trend is reversed in more polar solvents 
such as CH3CN, DMSO, and MeOH.  In these cases, 2 displays a higher quantum yield 
than 1.    
 The monoexponential fluorescence lifetimes of 1 and 2 are 3.0 and 2.7 ns 








 in ether are shorter (1.2 and 1.0 ns). The lifetime 
of 1 in methanol is substantially decreased (300 ps). Alkyl PPEs typically exhibit 
lifetimes of 300-700 ps in solution; their lifetimes in the solid state decrease considerably 
to around 70 ps due to planarization and aggregate/excimer formation.
19 
Aggregation is 
visible upon addition of 1 to methanol and is the likely cause for the dramatic decrease in 
fluorescence lifetime (Figure 4.5).  
       
Figure 4.5. Tyndall effect observed by passing a laser through 1 in MeOH (left) and 2 in H2O (right). 
 
 Upon dissolution of 2 to water, changes in photophysical properties are observed.  
When compared to 2 in methanol, both absorption and emission are redshifted with the 
quantum yield and fluorescence lifetime being significantly reduced. The fluorescence 
lifetime of 2 in water (500 ps) suggests that aggregation occurs; tyndall scattering is 
observed even in the most dilute aqueous solutions. 
 To further investigate this phenomenon, samples of an aqueous “suspension” of 2 
were investigated using TEM (Figure 4.6). We observe the formation of fairly 
monodisperse polymer nanospheres ranging from 50-100 nm. While interesting, this 
aggregate formation modulates the photophysical properties of 2, a potential problem for 
inclusion in biosensory applications. 
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Figure 4.6. TEM images of aggregates of 2 in water.  Aggregates were formed upon addition of a small 
amount of 2 in DMSO to a large volume of water. Scale bar = 100 nm. 
 
 Upon addition of TFA to 2 in water, we observe a significant blueshift in 
absorption (417 nm → 351 nm) and emission (583 nm → 489 nm); this is accompanied 
by a fiftyfold increase in quantum yield, from 0.001 to 0.05. The fluorescence lifetime 
also increases from 500 ps to 2.4 ns, and the Tyndall effect disappears, suggesting that 
2H
+
 does not aggregate in water. 
 Additionally, PPE 2 exhibits a particularly interesting quality that has never been 
observed with the small molecule cruciform analogues: the ability to extract metal ions 
from aqueous solution into the organic phase (Figure 4.7). For each metal tested, 100 mg 
of the corresponding triflate salt was dissolved in 10 mL H2O (10 mg/mL), to which an 
aliquot of 2 (dissolved in DCM) was added to the vial and shaken thoroughly. As seen in 
Figure 3.7, the emission was completely quenched upon binding with Hg
2+
, likely due to 
heavy atom effects. 
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Figure 4.7. Extraction of metals (PPE 2) from H2O into organic solution (DCM). Metal triflate salts were 




 PPE-PPV hybrid polymers offer a novel opportunity to construct longer 
wavelength emitting systems.  Herein, we report our first efforts to incorporate both 
donor-functionalized styryl sidechains and branched polyethylene glycol swallowtail 
sidechains into the PPEs.  The extraction of metal ions from aqueous to organic phases is 
an effect that is wholly unique among materials of this type; a full panel of metal 
extraction studies are currently in progress along with work towards developing new 




Materials and Methods 
 All chemicals and solvents were purchased from commercial sources and were 
used without further purification unless otherwise specified. All IR spectra were obtained 
using a Shimadzu FTIR-8400s spectrometer. 
1
H NMR spectra were recorded at 298 K on 
a 300 or 500 MHz spectrometer. Chemical shifts are reported in parts per million (ppm), 
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using residual solvent (chloroform-d or dimethylsulfoxide-d6) as an internal standard.  
The data is reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet,  br = broad), and integration.  
13
C HMR spectra were 
recorded at 400 MHz, and 
13
C chemical shifts () are referenced to residual CHCl3 at 
77.23 ppm or residual DMSO at 39.5 ppm.  All absorption spectra were collected using a 
Shimadzu UV-2401PC spectrophotometer.  All emission spectra were acquired using a 
Shimadzu RF-5301PC spectrofluorophotometer.  Quantum yields for the polymer was 
measured using standard procedures.
20
 In all cases, quinine sulfate and 2-aminopyridine 
were used as standards and all solutions were purged with nitrogen prior to measurement. 





 were synthesized according to previous reported 
literature procedures. 
 
Figure 4.8. Synthesis of monomer M1. 
 
Synthesis of M1 
 Compound S1 (2.55 g, 4.05 mmol) was placed in 50 mL THF followed by 
addition of potassium tert-butoxide (1.14 g, 10.13 mmol) and p-(N,N-
diethylamino)benzaldehyde and allowed to stir overnight at room temperature. The 
mixture was poured into 800 mL methanol and the resulting precipitate was collected via 
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vacuum filtration. The collected solid was purified by silica gel chromatography using 
dichloromethane as the eluent. The product was collected as an orange crystalline solid in 
62% yield. 
1
H NMR (300 MHz, CDCl3):  8.01 (s, 2H), 7.41 (d, 4H, J3, H,H = 8.7 Hz), 
6.94 (2d, 2H, J3 H,H = 15.9 Hz), 6.86 (d, 2H, J3 H,H =15.6 Hz), 6.66 (d, 4H, J3 H,H = 9 Hz), 
3.38 (q, 8H, J3 H,H = 6.9 Hz), 1.18 (t, 12H, J3 H,H = 6.9 Hz). 
13
C NMR (300 MHz, CDCl3): 
 147.77, 140.44, 135.44, 131.91, 128.35, 125.48, 123.98, 111.53, 100.15, 44.40, 12.63. 
IR (cm
-1
): 3417.63, 3195.83, 3068.53, 3028.03, 2960.53, 2931.60, 2597.94, 1872.75, 




Figure 4.9. Synthesis of monomer M2. 
 
Synthesis of M2 
 
 Monomer M1 (2.00 g, 2.95 mmol) was dissolved in THF (10 mL), 
dichloromethane (3 mL), and piperidine (2 mL) in a Schlenk flask under nitrogen purge. 
The flask was freeze-pump-thawed three times, after which (Ph3P)2PdCl2 (10 mg, 14.2 
mol) and CuI (5.6 mg, 29.5 mol) were added. The mixture was allowed to stir at room 
temperature for 24 h. The solution was diluted with dichloromethane and extracted with 
water four times. The organic layer was collected and the solvent removed under reduced 
pressure. The resulting solid was purified by silica gel chromatography using 
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dichloromethane as the eluent. The product was collected as a pale orange solid in 73% 
yield (1.33 g). 
1
H NMR (300 MHz, CDCl3):  7.73 (s, 2H,), 7.36 (m, 6H), 7.09 (d, 2H, J3 
H,H = 16.5 Hz), 6.64 (d, 2H, J3 H,H = 8.7 Hz), 3.37 (q, 8H, J3 H,H = 6.9 Hz), 1,171 (t, 12H, 
J3 H,H = 6.9 Hz), 0.31 (s, 18H). 
13
C NMR (300 MHz, CDCl3):  147.53, 137.48, 130.17, 
128.08, 128.00, 124.67, 121.38, 120.52, 111.57, 103.87, 100.03, 44.36, 12.65, 0.09. IR 
(cm
-1
): 3419.56, 3178.47, 3089.75, 3033.82, 2966.31, 2927.74, 2150.48, 1872.75, 




Figure 4.10. Synthesis of PPE 1. 
 
Synthesis of 1 
 Monomer M2 (0.753 g, 1.22 mmol) was combined with 2 mL THF and 1 g of 
potassium hydroxide in a Schlenk flask under nitrogen purge. After 10 minutes, monomer 
M3 (1.33 g, 1.22 mmol) and 4 mL THF were added to the flask, which was then frozen 
and purged three times, after which (Ph3P)2PdCl2 (4.28 mg, 6.1 µmol) and CuI (2.32 mg, 
12.2 µmol) were added. The mixture was allowed to stir at 35 
o
C for 48 h. The solution 
was poured into hexanes and the solid precipitate collected via vacuum filtration in 69% 
yield (1.11 g). The weight averaged molecular weight (Mw) was estimated to be 25.8 kDa 
with a polydispersity (Mw/Mn) of 1.5. Synthesis of 1H
+
 was performed by addition of 
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trifluoroacetic acid to pure 1. 
1
H NMR (300 MHz, DMSO-d6),  7.81 (m, 4H), 7.42 (m, 
8H), 7.2 (m, 4H), 6.6 (2H), 4.6 (m, 2H), 3.45 (m, 76H), 1.18 (m, 12H) Compound was 
not sufficiently soluble to obtain 
13
C NMR. IR (cm
-1
): 3427.27, 3033.82, 2966.31, 






[1] (a) Bunz, U.H.F. Chem. Rev. 2000, 100, 1605-1644. (b) Bunz, U.H.F. Adv. 
Polym. Sci. 2005, 177, 1-52. (c) Bunz, U.H.F. Macromol. Rapid Commun. 2009, 
30, 772-805. 
 
[2] (a) Wilson, J.N.; Bunz, U.H.F. J. Am. Chem. Soc. 2005, 127, 4124-4125. (b) 
Zucchero, A.J.; McGrier, P.L.; Bunz, U.H.F. Acc. Chem. Res. 2010, 43, 397-408. 
 
[3] Swager, T.M. Acc. Chem. Res. 2008, 41, 1181-1189. 
 
[4] Miranda, O.R.; You, C.C.; Phillips, R.L.; Kim, I.-B.; Ghosh, P.S.; Bunz, U.H.F.; 
Rotello, V.M. J. Am. Chem. Soc. 2007, 129, 9856-9857. 
 
[5] Kim, I.-B.; Shin, H.; Garcia, A.J.; Bunz, U.H.F. Bioconjugate Chem. 2007, 18, 
815-820. 
 
[6] McRae, R.L.; Phillips, R.L.; Kim, I.-B.; Bunz, U.H.F.; Fahrni, C.J. J. Am. Chem. 
Soc. 2008, 130, 7851-7853. 
 
[7] Phillips, R.L.; Miranda, O.R.; You, C.-C.; Rotello, V.M.; Bunz, U.H.F. Angew. 
Chem. Int. Ed. 2008, 47, 2590-2594. 
 
[8] Bunz, U.H.F.; Rotello, V.M. Angew. Chem. Int. Ed. 2010, 49, 3268-3279. 
 
[9] Kim, I.-B.; Bunz, U.H.F. J. Am. Chem. Soc. 2006, 128, 2818-2819. 
 
[10] (a) Pinto, M.R.; Kristal, B.M.; Schanze, K.S. Langmuir 2003, 19, 6523-6533. (b) 
Jiang, H.; Taranekar, P.; Reynolds, J.R.; Schanze, K.S. Angew. Chem. Int. Ed. 
2009, 48, 4300-4316. 
 
[11] Wilson, J.N.; Windscheif, P.M.; Evans, U.; Myrick, M.L.; Bunz, U.H.F. 
Macromolecules 2002, 35, 8681-8683. 
 
[12] Kim, I.-B.; Phillips, R.L.; Bunz, U.H.F. Macromolecules 2007, 40, 5290-5293. 
 61 
 
[13] Horner, L.; Hoffmann, H.; Wippel, H.G. Chem. Ber. 1958, 91, 61. 
 
[14] Horner, L.; Klink, W. Tetrahedron Lett. 1964, 36, 2467. 
 
[15] (a) Sonogashira, K. J. Organomet. Chem. 2002, 653, 46-49. (b) Negishi, E.; 
Anatasia, L. Chem. Rev. 2003, 103, 1979-2017. 
 
[16] (a) Zucchero, A.J.; Wilson, J.N.; Bunz, U.H.F. J. Am. Chem. Soc. 2006, 128, 
11872-11881. (b) Hauck, M.; Schӧnhaber, J.; Zucchero, A.J.; Hardcastle, K.I.; 
Müller, T.J.J.; Bunz, U.H.F. J. Org. Chem. 2007, 72, 6714-6725. 
 
[17] Tolbert, L.M.; Solntsev, K.M. Acc. Chem. Res. 2002, 35, 19-27. 
 
[18] Sluch, M.I.; Godt, A.; Bunz, U.H.F.; Berg, M.A. J. Am. Chem. Soc. 2001, 123, 
6447-6448. 
 
[19] Bunz, U.H.F.; Imhof, J.M.; Bly, R.K.; Bangcuyo, C.G.; Rozanski, L.; Vanden 
Bout, D.A. Macromolecules 2005, 38, 5892-5896. 
 
[20] “A Guide to Recording Fluorescence Quantum Yields.” Horiba Jobin Yvon Ltd. 
available online: http://www.jobinyvon.co.uk/ukdivisions/Fluorescence/plqy.html 
 
[21] Wilson, J.M.; Josowicz, M.; Wang, Y.; Bunz, U.H.F. Chem. Commun. 2003, 39, 
2962-2963. 
 
[22] Khan, A.; Müller, S.; Hecht, S. Chem. Commun. 2005, 5, 584-586. 
 62 
CHAPTER 5 
DISCRIMINATION OF ORGANIC ACIDS USING A THREE 
MOLECULE ARRAY BASED UPON CRUCIFORM 
FLUOROPHORES 
Introduction 
 Tuning and enhancing the discriminatory sensory responses of fluorophores or 
chromophores towards classes of compounds emerges as an important topic at the 
interface of analytical, biological, organic, materials and supramolecular chemistry.
1
 
Application of array-based sensing concepts by Suslick et al.,
2
 Lavigne et al.,
3
 and by 
Anslyn et al.
4
 provides material systems that discern, with surprising selectivity, even 
complex mixtures of similar compounds. Attention-grabbing examples are the 
discrimination of different whiskey brands
5
 or the identification of a selection of coffee 
grounds (Starbucks vs. Folgers)
6
 by small arrays of chromophores immobilized on 
suitable substrates. The concept is known as chemical "tongue" or chemical "nose" and 
works also for example to discriminate amines.
7
 Are there generalized conditions for 
chemical tongues to be particularly successfully applied? They work best when reporting 
the departure of the analyte from a defined composition, identifying (undesired) changes 
in an otherwise regulated/defined environment. For that reason, even complex mixtures, 
such as alcoholic spirits, coffee grounds, beers, etc. can be “fingerprinted” and compared 
to each other by a specific set of sensory compounds or arrays. Chemical tongues are 
therefore particularly good for sophisticated quality control. 
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 The detection of adulterated or counterfeit drugs is critically important as one 
wants to avoid ingestion of poisonous substances, or the use of (for example) malaria 
medications that contain the wrong or adulterated ingredients or are just expired.
8
 A 
significant number of prescription drugs display either free amines (often as their 
ammonium salts) or free carboxylic acids (occasionally in their salt form). Examples for 
the latter class are aspirin, ibuprofen, Artesunate®, Lipitor®, Crestor®, Cellcept® and 
Sector®. A simple fluorescence-based test discerning organic acids might therefore be of 
great interest and potential to perform quality control in drug samples of questionable 
origin (internet pharmacies, gray market). Such a tool would be useful for public health 
applications. In this communication we describe the identification of ten structurally 
related acids B-K derived from benzoic and phenylacetic acids by a small fluorophore 
array of 1,4-distyryl-2,5-bisarylethynylbenzenes (XF1- XF3) in different solvents. 
 
Figure 5.1. Reactive 1,4-distyryl-2,5-bisarylethynylbenzenes. 
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Figure 5.2. Benzoic and phenylacetic acid derivatives analyzed. 
Results and Discussion 
 In a first experiment we investigated the interaction of phenylacetic acid (F) with 
XF1
9
 to obtain the concentration dependence of the response of the XF to the acid.
10
 At 
concentrations above 500 mg of C in a 20 mL vial (25 gL
-1
) the fluorescence starts to 
shift from green to blue due to the protonation of the aniline nitrogens (Figure 5.3). This 




Figure 5.3. Digital photograph of XF1 with increasing amounts of phenylacetic acid in dichloromethane. 
 
 To determine if different weak acids are differentially recognized, we exposed the 
acids B-K towards a small cruciform array (18 members: 3 cruciforms in 6 solvents each) 
at an acid concentration of 25gL
-1
 (Figure 5.4). The results are striking, as all carboxylic 
acids can be discerned, even though the pKa differences are small in some cases. Not 
unsurprisingly, the most acidic analytes (dichlorobenzoic acid J, iodosalicylic acid K) 
show the largest changes in the response patterns, as could be expected. Extraction of the 
RGB values from a photograph of the array using Color Contrast Analyzer
11
, a 




Figure 5.4. Photograph of three XFs (1-3) in six different solvents (1 = DCM, 2 = EtOAc, 3 = MeCN, 4 = 
DMF, 5 = iPrOH, 6 = MeOH) and exposed to ten different carboxylic acids (A = XF reference emission, B 
= 4-Hydroxybenzoic acid pKa = 4.55; C = 4-Hydroxyphenylacetic acid pKa = 4.5; D = Ibuprofen pKa = 
4.5; E = Aspirin pKa = 4.4; F = Phenylacetic acid, pKa = 4.28; G = 4-Chlorophenylacetic acid pKa = 4.19; 
H = Benzoic acid, pKa = 4.19; I = 3,5-Dihydroxybenzoic acid, pKa = 4.04; J = 2,4-Dichlorobenzoic acid 
pKa = 2.76; K = 5-Iodosalicylic acid pKa = 2.67). All photographs were taken under blacklight at an 
excitation wavelength of 366 nm. 
 
 
 A differential fluorescence correlation plot obtained by multivariate analysis of 
variance (MANOVA) identifies unknowns by their fluorescence signature (Figure 5.5) 
and demonstrates that the ten acids are reliably discerned. In the multivariate analysis of 
variance approach we are calculating standard deviations  of the individual RGB values 
related to a particular compound. This approach allows revealing properties and structure 
relationships of the cruciform fluorophores XF1, XF2 and XF3, solvents and analytes. 
There are correlations between -values of different cruciforms dissolved in the same 
solvent and the same cruciforms dissolved in different solvents, however the -values are 
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characteristic, making an ambiguous assignment of analytes by using orthogonal 




































Figure 5.5. Differential correlation plot of the fluorescence response of the different carboxylic acids by 
the 18-member XF-array. The z-axis represents the relative standard deviation  of the R,G and B values 





Figure 5.6. Correlation plot of pKa values and the relative standard deviation  of the RGB values a) XF2 
dissolved in EtOAc, b) XF3 dissolved in EtOAc; Red circle: acids with a hydroxyl group; blue circle: acids 
with a halogen substituent; green circle: acids without any functionality, yellow circle: acid with hydroxyl 





















































Figure 5.7. 3D plot of two cruciform fluorophores XF1 and XF3 in three solvents. The data points 
represent well separated standard deviations of the individual analytes B to K. 
 
 Interestingly, we found, that XF2 in EtOAc correlates well with the pKa value of 
the analytes (related to B with the highest pKa value), while XF3 results in clustered 
response that shows a correlation to the chemical structures of the acids (Figure 5.6). All 
of the nonfunctional acids are clustered (exception: 4-chlorobenzoic acid) in the green 
region, acids featuring free hydroxyl groups (red circle) are grouped together, while the 
two most acidic halogenated benzoic acids J and K show the greatest -values. Here too, 
the presence of the hydroxyl group seems to lower the -value for J as compared to that 
of K.  So interestingly enough, XF3 appears to recognize functional features, while XF2 
exhibits responses that strictly correlate with the pKa values of the acids. Attempts to 
convert the spectroscopic (as opposed to the photographic) responses (response spectra of 
XF2 and XF3 with B-J) to RGB values and functionally map the information from the 
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spectra to those obtained from the photographs is currently not feasible, as there is no 
simple algorithm that could convert fluorescence spectra directly into RGB values. 
In an effort to achieve unambiguous detection of analytes with the smallest number of 
fluorophores – solvent combinations we analyzed 3D datasets of fluorophoric cruciform 
sensors in various solvents to find the largest differences in the σ-values. With only three 
different fluorophore–solvent combinations (Figure 5.7), the minimal set, the analytes B 
to K can be identified. 
 In conclusion, a fluorophore array (three fluorophores, XF1-XF3 in six solvents 
each) using digital photography discerns ten different carboxylic acids by differential 
fluorescence response, even though some of the acids have pKa values that are close to 
each other. The array is considerably more selective than a simple pH-‘paper’.  Its 
selectivity should be further tuned up when other more basic or hydrogen-bonding XF are 
included.  The apparent disadvantage that one has to use high concentrations of 
carboxylic acids to elicit a response is not an issue. Drug formulations (i.e. tablets, gel 
caps etc.), the final target, can be crushed and used in concentration necessary to elicit a 
robust fluorescence response. One would then only have to compare the (photographical 
reproduced) profile of an original tablet with that of the sample at hand or use a statistical 
algorithm. This concept should be well suited to identify and discern drug formulations 
that are acidic in nature. 
Experimental Procedures 
 
Materials and Instruments 
 All organic acids and solvents were purchased from commercial sources and were 
used without further purification. All emission spectra were acquired using a Shimadzu 
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RF-5301PC spectrofluorophotometer. Photographs were taken with a Canon EOS 30D 
digital camera equipped with a Canon EFS 18-55mm zoom lens. Photograph exposure 
times were varied for each solution to produce images reflecting the color of emission 
(0.25 s – 15 s). All calculations were performed by a program XPattern.exe written in 
Delphi (Embarcadero Technologies, South San Francisco, USA). Correlation analysis 
was performed in Microsoft Excel 2007 (Microsoft Corp., Redmond, Washington, USA) 
and OriginPro 8.5 (Origin Lab Corporation, One Roundhouse Plaza, Northhampton, 
USA). 
Initial Acid Detection Study 
 To identify working acid concentrations and the ability to distinguish compounds, 
increasing amounts of phenylacetic acid were dissolved in dichloromethane (Figure 5.8), 
followed by 10 μL XF1 stock solution (50 mg/10 mL DCM). Variations in fluorescence 
were first observed at concentrations of 500 mg/16 mL. This study was also performed 
with benzoic acid (Figure 5.9), where little change in emission was observed. It was also 




Figure 5.8. Increasing concentrations of phenylacetic acid in DCM/XF1. 
 
 
Figure 5.9. Increasing concentrations of benzoic acid in DCM/XF1. 
 
Initial Solvent Study 
 To identify representative solvents for the array, benzoic acid and phenylacetic 
acid were dissolved at various concentrations in three solvents: non-polar (DCM, figure 
5.9), polar-aprotic (CH3CN, figures 5.10 & 5.11), and polar-protic (MeOH, figures 5.12 
& 5.13). Upon observation of fluorescent changes, the ideal concentration for the primary 
investigation was decided to be 1 g acid/16 mL solvent. Dye concentrations were kept 
constant at the addition of 10 μL stock solution (50 mg XF/10 mL DCM). 
 









Figure 5.12. Increasing concentrations of benzoic acid in MeOH/XF1. 
 
Calculation of RGB Changes 
 Upon completion of the chemical array, representative colors from each 
photograph were cut (via Adobe Photoshop) and copied into a table. An identical table 
was generated where all cells were filled with the corresponding reference XF emission, 
and the pictures were subtracted using the free downloadable program, ImageJ (Figure 
5.13). RGB values were extracted from the generated image for a differential 
fluorescence correlation plot using multivariate analysis of variance (MANOVA). 
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 To better visualize the relative intensities of the observable emissions, 
fluorescence spectra were recorded for all acid/XF2 and acid/XF3 combinations in 
EtOAc; these systems best represented reaction dependence on pKa (Figure 5.14) and 
structural features (Figure 5.15). 
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Figure 5.14. Emission spectra of acids 1-10/XF2 in EtOAc.* Spectra were not normalized to show relative 
intensities of fluorescence upon reaction. 1. Benzoic Acid, 2. Phenylacetic Acid, 3. 4-OH Benzoic Acid, 4. 
3,5-diOH Benzoic Acid, 5. 2,4-diCl Benzoic Acid, 6. 5-Iodosalicylic acid**; 7. 4-OH Phenylacetic Acid, 8. 
4-Cl Phenylacetic Acid; 9. Asprin, 10. Ibuprofen; *Fluorimeter slit width constant @ 1.5 mm. The sharp 




Figure 5.15. Emission spectra of acids 1-10/XF3 in EtOAc.* Spectra were not normalized to show relative 
intensities of fluorescence upon reaction. 1. Benzoic Acid, 2. Phenylacetic Acid, 3. 4-OH Benzoic Acid, 4. 
3,5-diOH Benzoic Acid, 5. 2,4-diCl Benzoic Acid, 6. 5-Iodosalicylic acid**; 7. 4-OH Phenylacetic Acid, 8. 
4-Cl Phenylacetic Acid; 9. Asprin, 10. Ibuprofen; *Fluorimeter slit width constant @ 1.5 mm. **Appears at 
baseline, quenched relative to others. 
 
Multivariate Analysis of Variance of the Experimentally Obtained RGB Values 
 The obtained RGB values of individual samples are used as R, G, and B-vectors 
to calculate standard deviations related to a standard (std). The individual R, G, and B 
values are treated as independent vectors and are not averaged. The relative standard 
deviation σi gives a single value, which can be correlated with chemical properties to 
reveal relationships (Figure 5.16).  
 
 
Figure 5.16. Correlation plot of pKa values and the relative standard relative standard deviation σ of the 
RGB values a) XF2 dissolved in EtOAc, b) XF3 dissolved in EtOAc; red circle: acids with a hydroxyl 
group; blue circle: acids with a halogen substituent; green circle: acids without any functionality, yellow 
circle: acid with hydroxyl and halogen substituents. 
 
 The relative standard deviation σi of a single compound can be calculated 
according to equation 5.1. 
 
Equation 5.1. Calculating relative standard deviation σi. 
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These values can be correlated in 2D and 3D plots to find cruciform fluorophores and 
solvents with large differences in σi of the individual analytes (Figure 5.17). Analysis of 
such plots gives measures of suitable solvent/cruciform fluorophore combinations to 
unambiguously identify single analytes. The relative σ values were also correlated with 
the pKa values of the analytes (Figure 5.18). 
Figure 5.17. Correlation plot of pKa values and the relative standard relative standard deviation σ of the 
RGB values of samples. a) XF1 in EtOAc, b) XF1 in DCM, and c) XF3 in DCM. 
 
 
Figure 5.18. Correlation plot of pKa values and the relative standard deviation σ of the RGB values of 
samples. a) XF2 in DCM, b) XF3 in DCM, and c) XF1 in DMF. 
 
 Analysis of cruciform fluorophore – solvent – analyte data is performed in a 
similar way by extending the equation of the relative standard deviation σi to 3D datasets 
according to equation 5.2. 
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Equation 5.2. Calculating relative standard deviation σi in three dimensions. 
 
  
This approach allowed us not only to find out suitable combinations of 
fluorophoric sensors, but also to discriminate among and identify unknown compounds 
by statistical analysis of calibration data. Evaluation of an unknown data set yielded 
100% accuracy in assignment: 
________________________________________________________________________ 
Ibuprofen 
Ibuprofen Unknown Group 1 
Ibuprofen 
3,5-Dihydroxybenzoic acid 
3,5-Dihydroxybenzoic acid Unknown Group 2 
3,5-Dihydroxybenzoic acid 
Benzoic acid 
Benzoic acid Unknown Group 3 
Benzoic acid 
Phenylacetic acid 




 Fluorescence photographs were recorded in darkroom conditions under UV lamps 
as illustrated in figure 5.19. 
  
 
Figure 5.19. Darkroom setup for photographing vials (photo taken under ambient light; all published 
results were recorded in the dark). b) overhead sketch of darkroom setup. Two hand held UV-lamps with an 
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CHAPTER 6 
IDENTIFICATION OF PHARMACEUTICALS: 
USING CRUCIFORM FLUOROPHORE ARRAYS TO 
DISCRIMINATE AMONG OVER-THE-COUNTER DRUGS 
Introduction 
 
 Recent developments in the “chemical tongue” concept have given rise to the use 
of array-based sensors to discriminate and identify complex mixtures.
1-5
 While this 
technology is limited only to compound identification (i.e., no single components of a 
mixture can be quantified), such sensors are still quite desirable for applications in quality 
control and anti-counterfeiting assays. Specifically, array based sensors have been shown 
to be a quick and easy method of compound identification once an appropriate library of 
known analytes has been built.
6
 
 This project seeks to expand on the recent results that are outlined in Chapter 5 of 
this dissertation where a sensor array based on three cruciform fluorophores were used to 
discriminate various aromatic organic acids.
6
 In our previous investigations, the analytes 
were chosen based on structural similarities to the active ingredients in many common 
pharmaceuticals (figures 6.1 and 6.2). In addition to elucidating the ability to discriminate 
various organic acids, we have shown that our array can successfully identify analytically 










Figure 6.1. Organic acids studied with initial fluorophore array. (B = 4-Hydroxybenzoic acid pKa = 4.55; 
C = 4-Hydroxyphenylacetic acid pKa = 4.5; D = Ibuprofen pKa = 4.5; E = Aspirin pKa = 4.4; F = 
Phenylacetic acid, pKa = 4.28; G = 4-Chlorophenylacetic acid pKa = 4.19; H = Benzoic acid, pKa = 4.19; I 
= 3,5-Dihydroxybenzoic acid, pKa = 4.04; J = 2,4-Dichlorobenzoic acid pKa = 2.76; K = 5-Iodosalicylic 







Figure 6.2. Chemical structures of common pharmaceuticals. Initial studies in organic acid discrimination 




Experimental Design, Discussion, and Results 
 
  For this study, a large spectrum of samples was required to accurately paint a 
picture of true pharmaceutical discrimination. To this effect, twenty over-the-counter 
drugs were purchased from a local pharmacy and organized based on the ailment the drug 
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was designed to counteract (figure 6.3). In doing this, we hoped to answer an ancillary 
question in the process of identifying individual drugs: do families of drugs react in a 
similar fashion, that is to say, do they have similar fluorescent "finger-prints", and if so, 
can we still distinguish individuals among the family as we were able to do with organic 
acids that contained similar functionalities. 
 
Figure 6.3. List of pharmaceuticals categorized based on the ailment they were designed to counteract. 
 
 In addition to choosing a larger analysis set, modifications were made to the 
design of the fluorophore array (figure 6.4). Based on the results outlined in Chapter 5, 
the cruciforms (XFs) in the array were changed to include two pyridyl-functionalized 
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XFs, with XF1 containing pyridyl units on the electron-rich styryl axis, and XF2 being 
substituted with pyridyl units on the electron-poor alkynyl axis. Though both compounds 
exhibit a reference emission in the blue region of the spectrum, it was thought that the 
differences in the electronic environments in XF1 and XF2 would provide enough 
differences in reactivity to aid in the discrimination of the analytes.  
 Finally, XF3 was selected as a fully functionalized cruciform, containing 
dibutylamino groups on the distyrylbenzene axis and pyridyl units on the alkynyl axis; 
we have previously reported that XF3 exhibits a distinct two-stage response, where the 
axes will react individually based on the concentration or pH of the analyte being tested.
7
 
With the inherent ability to  provide two discrete changes in emission, XF3 added 
another layer of depth to the sensing capability of this fluorophore array. 
 
Figure 6.4. Cruciforms chosen for fluorophore array. 
 
 Before the initial fluorescence studies began, a problem was encountered 
regarding our choice of solvent system. Attempts at dissolution into common organic 
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solvents such as dichloromethane and acetonitrile were unsuccessful, causing us to 
modify the solvents to reflect highly polar environments, and in two cases, dilute the 
organic portion with increasing amounts of water. Even still, in all cases tested the 
solutions were saturated and a significant amount of the pill remained as a solid in the test 
vial. For the purposes of these experiments, this effect was not treated as a problem, but 
instead, an advantage in demonstrating the practicality of our experimental design. 
 For each pharmaceutical tested, the amount used was based on one full dosage of 
the individual drug. The thought behind this testing process was based on practical 
applications of a "chemical-tongue" device. If such an apparatus were designed to be 
used outside of a laboratory for anti-counterfeiting testing, the user would have the ability 
to test a full dosage of the medication as compared to a predetermined amount that a 
research lab might investigate for the purposes of research (i.e., a 10 mg sample from a 
pill as compared to a full tablet). 
 With the fluorophore array redesigned for the pharmaceutical analytes, solutions 
were prepared in a manner analogous to those reported in Chapter 5. A single dosage of 
each drug was prepared and placed in a four dram vial, which was then filled with each of 
the five solvents and a 10 μL aliquot of dye. Once prepared, digital photographs were 
taken of each vial under ultra-violet light (λmax= 365 nm) and a portion of each image that 
most accurately represented the emission as a whole was then inserted into a table (figure 
6.5). Once the table was complete, an identical table was prepared, with each cell being 
filled with a photograph of the corresponding XF reference emission. The colors in these 
tables were then subtracted, generating the final color difference profiles (figures 6.6 and 
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6.7). The color profiles (RGB values) of each cell in the color difference profiles were 




Figure 6.5. Color profiles of pharmaceuticals 1-20 upon exposure to XF1-3 in five different solvents. 
Solvent system: ethyl acetate, isopropanol, methanol, 90:10 methanol:water, and 50:50 methanol:water. 
Pharmaceuticals: 1. CVS Arthritis Pain Relief; 2. CVS Ibuprofen Liqui-Gel; 3. CVS Extra Strength Pain 
Relief; 4. CVS Migraine; 5. ExcedrinTM Migraine; 6. AdvilTM; 7. Bayer Low Dose; 8. Junior Strength 
Ibuprofen; 9. CVS Aspirin Low Dose; 10. Infant Advil; 11. CVS Children's Pain Relief; 12. Pedia Cure - 
Infant; 13. Advil Congestion; 14. AdvilTM PM; 15. CVS Multisymptom Cold; 16. Extra Strength Pain Relief 
PM; 17. Motrin PM; 18. CVS Allergy; 19. CVS Allergy Relief; 20. ClaritinTM. Vials were photographed 
under a handheld UV light (λmax ex = 365 nm) using a Canon EOS 30D digital camera equipped with a 
Canon EFS 18-55mm zoom lens. Photograph exposure times were varied for each solution to produce 










Figure 6.7. Color difference map of the XF reference emissions subtracted from the change in color. 
 
 After the first analysis, collaborators were unsuccessful in discriminating any of 
the samples in the library during a blind study of unknown compounds. Subsequent 
measurements and data collection is planned in the coming months, along with the 
possible substitution of XF1 or XF2 for a fluorophore with a distinctly different reference 







 Though this project is not yet complete, it has reached the final stages of analysis; 
interpretation of the data has started to elucidate some of the answers that we were 
examining at the beginning of this project. From a qualitative standpoint, we can visually 
observe different fluorescent "fingerprints" for each pharmaceutical. Unfortunately, this 
analysis has yet to translate into statistical discrimination between the analytes. It is our 
hope that through a small modification in the fluorophore system we can achieve 100% 
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 In summation, this dissertation was designed to provide a precedence for the 
synthesis and application of advanced cross-conjugated motifs. From the development of 
"three-armed" cruciforms to the post-functionalization of a poly(para-
phenyleneethynylene) backbone, the projects described herein have spanned the breadth 
of chromophore research undertaken in the Bunz group and taken previously successful 
projects in new directions regarding applications in fluorescence sensing. 
 While advanced scientific instrumentation can often characterize molecules and 
provide necessary information for the identification of compounds, these techniques are 
often impractical when working outside of the laboratory, in an off-site type of setting. 
For such endeavors, the ability to quickly extract chemical information may be necessary, 
and users must look to alternative techniques. The idea of a chemical tongue relies on the 
concept of "finger-printing" molecules via some molecular response based on the 
addition or removal of a defined analyte. By preparing a number of "finger-prints" into a 
digital library, one could imagine a mobile chemical identification unit, without any 
complex scientific instrumentation, merely a hand-held device that could identify and 
discriminate compounds based on knowledge stored in the library. Chapters five and six 
in this dissertation outline our initial attempts at designing a fluorescence sensor based on 
the chemical tongue concept. At the end of my graduate career, I am now of the opinion 
that chemical sensing and the practical application of the fluorophores discussed herein 
should dictate the future of research related to these compounds. 
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 When considering research in the Bunz group, there was one key discovery that 
propagated all of the research serving as the background to this dissertation. In 2003, 
Bunz and Wilson successfully developed cross-conjugated, small molecule PPE/PPV 
hybrids, deemed cruciforms (XFs), from which they were able to generate fluorescent 
responses upon binding of metals and protons to various functionalities in the 
compounds.
1
 Over the past decade, this concept has been expanded into multiple projects 
and been the primary research focus of three graduate students and multiple post-doctoral 
students in the Bunz group. This dissertation is only one snippet of a larger body of work 
in the area of responsive fluorophores. Herein, the principle goal was to exhibit the 
viability of cross-conjugated materials, be them oligo- or polymeric in nature, in practical 
sensing techniques. It is my hope that this document will serve as a stepping-stone for a 
future researcher, one who will see the work accomplished in this document and start 





DEVELOPMENT OF GREEN FLUORESCENT PROTEIN 
ANALOGUES AS FLUORESCENT PROBES FOR PEROXISOME 
PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA BINDING 
 
Introduction 
 My involvement in this project originally developed as an extension of my 
interest in fluorescent conjugated materials and the need for the development of new 
ligands in the Tolbert/Azizi collaboration. This appendix describes the synthesis (Figure 
XX1) and characterization of green fluorescent protein (GFP) analogues for use as 
peroxisome proliferator-activated receptor gamma (PPAR-γ) probes. 
 One of the primary foci of research in the Tolbert group has been the elucidation 
of GFP chromophore binding and how it relates to fluorescence.
1 
In the past decade it has 
been revealed that the binding environment, specifically the rigidity of the GFP 
chromophore itself, is the integral means by which fluorescence is obtained. When 
discussing the photophysics of the GFP chromophore, it is important to note the two 
potential means of twisting that lead to a decay of the emission (figure A.1): the single 




































Figure A.1. Modes of twisting for GFP chromophore derivatives. 
 
When these twisting modes are restricted (i.e., the molecule is bound), planarity 
of the chromophore is maintained in the trans- position, generating a fluorescent state. 
The naturally occurring example of this effect is shown with the wild-type GFP 
chromophore bound in an 11-strand β-barrel.
3 
This effect has been mimicked via binding 





, binding to proteins,
6
 aggregation with cholate salts,
7
 and 
most recently, via binding to nuclear receptors.
8
  
The importance of binding of GFP analogues to nuclear receptors (NRs) lies in 
the ability to track the fluorogens in vivo.
9
 The specific focus of this project was to the 
design ligands to bind proliferator-activated receptor-gamma (PPAR-γ), a nuclear 
receptor known to regulate fatty acids and the metabolism of glucose.
10
 To this effect, 
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molecules mimicking fatty acids moieties were synthesized to maximize the potential of 
ligand binding (figure A.2). 
 
 
Figure A.2. General synthesis of imidazolidinone ligands. 
 
Current Progress and Future Work 
 
Initially, this project has been aimed at synthesizing a wide range of compounds 
of varying length using known procedures
11-12
 in the effort to determine a relative size of 
ligand that is able to fit into the binding pocket of PPAR-γ. While this project is only in 
the initial stages, at present time, eight imidazolidinones have been successfully 
synthesized, and we are awaiting the results of cell culture binding studies, which is to be 
undertaken by collaborators. 
 
Experimental Procedures 
Materials and Methods 
All chemicals and solvents were purchased from commercial sources and were 
used without further purification unless otherwise specified. 
1
H NMR spectra were 
recorded at 298 K on a 300 MHz spectrometer. Chemical shifts are reported in parts per 
million (ppm), using residual solvent (chloroform-d) as an internal standard.  The data is 
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reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet, br = broad), and integration. 
Synthesis and Characterization Data 




Figure A.3. Synthesis of imine 1. 
 
Synthesis of 1 
 Sodium hydroxide (732 mg, 1.1 mol eq) was dissolved into 2 mL methanol in a 
four dram vial followed by addition of 4-aminobutanoic acid (1.89 g, 1.1 mol eq.). After 
the amino-acid had fully dissolved, 4-(1-methylethyl)tolualdehyde (2 g, 0.01665 mol) 
was added via syringe to the reaction mixture. The reaction vessel was capped with a 
rubber stopper, vented to the atmosphere with an 18 gauge needle, and allowed to stir for 
24 hrs, at which time the solvent was removed under reduced pressure, yielding a white 
solid. The crude product was washed with diethyl ether (10 mL, 3x) and the solid was 
collected via vacuum filtration. 
 
 
Figure A.4. Synthesis of imine 2. 
 
Synthesis of 2 
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 Sodium hydroxide (733 mg, 1.1 mol eq) was dissolved into 5 mL methanol in a 
four dram vial followed by addition of 11-aminoundecanoic acid (3.69 g, 1.1 mol eq.). 
After the amino-acid had fully dissolved, 4-tolualdehyde (2 g, 0.01665 mol) was added 
via syringe to the reaction mixture. The reaction vessel was capped with a rubber stopper, 
vented to the atmosphere with an 18 gauge needle, and allowed to stir for 24 hrs, at which 
time the solvent was removed under reduced pressure, yielding a white solid. The crude 
product was washed with diethyl ether (10 mL, 3x) and the solid was collected via 
vacuum filtration, yielding the product as a white solid (2.19 g, 44%). 
 
Figure A.5. Synthesis of imine 3. 
 
Synthesis of 3 
 Sodium hydroxide (594 mg, 1.1 mol eq) was dissolved into 3 mL methanol in a 
four dram vial followed by addition of 6-aminohexanoic acid (1.95 g, 1.1 mol eq.). After 
the amino-acid had fully dissolved, 4-isopropylbenzaldehyde (2 g, 0.0135 mol) was 
added via syringe to the reaction mixture. The reaction vessel was capped with a rubber 
stopper, vented to the atmosphere with an 18 gauge needle, and allowed to stir for 24 hrs, 
at which time the solvent was removed under reduced pressure, yielding a white solid. 
The crude product was washed with diethyl ether (10 mL, 3x) and the solid was collected 
via vacuum filtration, yielding the product as a white solid. 
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Figure A.6. Synthesis of imine 4. 
 
Synthesis of 4 
 Sodium hydroxide (542 mg, 1.1 mol eq) was dissolved into 3 mL methanol in a 
four dram vial followed by addition of 4-aminobutanoic acid (1.40 g, 1.1 mol eq.). After 
the amino-acid had fully dissolved, 4-(1,1-dimethylethyl)benzaldehyde (2 g, 0.01233 
mol) was added via syringe to the reaction mixture. The reaction vessel was capped with 
a rubber stopper, vented to the atmosphere with an 18 gauge needle, and allowed to stir 
for 24 hrs, at which time the solvent was removed under reduced pressure, yielding a 
white solid. The crude product was washed with diethyl ether (10 mL, 3x) and the solid 
was collected via vacuum filtration, yielding the product as a white solid. 
 
Figure A.7. Synthesis of imine 5. 
 
Synthesis of 5 
  
Sodium hydroxide (733 mg, 1.1 mol eq) was dissolved into 3 mL methanol in a 
four dram vial followed by addition of 6-aminohexanoic acid (2.40 g, 1.1 mol eq.). After 
the amino-acid had fully dissolved, 4-tolualdehyde (2 g, 0.01665 mol) was added via 
syringe to the reaction mixture. The reaction vessel was capped with a rubber stopper, 
vented to the atmosphere with an 18 gauge needle, and allowed to stir for 24 hrs, at which 
time the solvent was removed under reduced pressure, yielding a white solid. The crude 
product was washed with diethyl ether (10 mL, 3x) and the solid was collected via 
vacuum filtration, yielding the product as a white solid.  
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Figure A.8. Synthesis of imine 6. 
 
Synthesis of 6 
Sodium hydroxide (656 mg, 16.4 mmol) was dissolved into 3 mL methanol in a 
four dram vial followed by addition of 4-aminobutanoic acid (1.69 g, 16.4 mmol). After 
the amino-acid had fully dissolved, 4-ethylbenzaldehyde (2 g, 14.91 mmol) was added 
via syringe to the reaction mixture. The reaction vessel was capped with a rubber stopper, 
vented to the atmosphere with an 18 gauge needle, and allowed to stir for 24 hrs, at which 
time the solvent was removed under reduced pressure, yielding a white solid. The crude 
product was washed with diethyl ether (10 mL, 3x) and the solid was collected via 
vacuum filtration, yielding the product as a white solid.  
 
Figure A.9. Synthesis of imine 7. 
 
Synthesis of 7 
Sodium hydroxide (502 mg, 1.1 mol eq) was dissolved into 3 mL methanol in a 
four dram vial followed by addition of 6-aminohexanoic acid (1.64 g, 1.1 mol eq.). After 
the amino-acid had fully dissolved, 4-ethylbenzaldehyde (1.53 g, 0.0114 mol) was added 
via syringe to the reaction mixture. The reaction vessel was capped with a rubber stopper, 
vented to the atmosphere with an 18 gauge needle, and allowed to stir for 24 hrs, at which 
time the solvent was removed under reduced pressure, yielding a white solid. The crude 
 98 
product was washed with diethyl ether (10 mL, 3x) and the solid was collected via 
vacuum filtration, yielding the product as a white solid. 
 
Figure 1.10. Synthesis of imine 8. 
 
Synthesis of 8 
Sodium hydroxide (594 mg, 1.1 mol eq) was dissolved into 3 mL methanol in a 
four dram vial followed by addition of 4-aminobutanoic acid (1.53 g, 1.1 mol eq.). After 
the amino-acid had fully dissolved, 4-isopropylbenzaldehyde (2.0 g, 0.0135 mol) was 
added via syringe to the reaction mixture. The reaction vessel was capped with a rubber 
stopper, vented to the atmosphere with an 18 gauge needle, and allowed to stir for 24 hrs, 
at which time the solvent was removed under reduced pressure, yielding a white solid. 
The crude product was washed with diethyl ether (10 mL, 3x) and the solid was collected 
via vacuum filtration, yielding the product as a white solid. 
 
Figure A.11. Synthesis of imine 9. 
 
Synthesis of 9 
  
Sodium hydroxide (542 mg, 1.1 mol eq) was dissolved into 3 mL methanol in a 
four dram vial followed by addition of 6-aminohexanoic acid (2.73 g, 1.1 mol eq.). After 
the amino-acid had fully dissolved, 4-isopropylbenzaldehyde (2.0 g, 0.0123 mol) was 
added via syringe to the reaction mixture. The reaction vessel was capped with a rubber 
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stopper, vented to the atmosphere with an 18 gauge needle, and allowed to stir for 24 hrs, 
at which time the solvent was removed under reduced pressure, yielding a white solid. 
The crude product was washed with diethyl ether (10 mL, 3x) and the solid was collected 
via vacuum filtration, yielding the product as a white solid (2.89 g, 85%). 
 
Figure A.12. Synthesis of imidazolidinone 1C. 
 
Synthesis of 1C 
 Compound 1 (500 mg, 0.00243 mol) was dissolved into a minimal amount of 
methanol (2 mL) in a six dram vial, followed by addition of 10 (427 mg, 1.1 mol eq.) to 
the reaction vessel via syringe. The mixture was allowed to stir at room temperature for 
24 hrs, at which point the solvent was removed under reduced pressure. The resulting 
yellow solid was then washed with diethyl ether (10 mL, 3x) and collected via vacuum 
filtration, yielding the final product as a yellow solid (210 mg, 30%). 
 
Figure A.13. Synthesis of imidazolidinone 3C. 
 
Synthesis of 3C 
Compound 3 (500 mg, 0.00191 mol) was dissolved into a minimal amount of 
methanol (2 mL) in a six dram vial, followed by addition of 10 (335 mg, 1.1 mol eq.) to 
the reaction vessel via syringe. The mixture was allowed to stir at room temperature for 
24 hrs, at which point the solvent was removed under reduced pressure. The resulting 
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yellow solid was then washed with diethyl ether (10 mL, 3x) and collected via vacuum 
filtration, yielding the final product as a yellow solid (135 mg, 21%). 
 
Figure A.14. Synthesis of imidazolidinone 4C. 
 
Synthesis of 4C 
Compound 4 (500 mg, 2.02 mmol) was dissolved into a minimal amount of 
methanol (2 mL) in a six dram vial, followed by addition of 10 (354 mg, 2.22 mmol) to 
the reaction vessel via syringe. The mixture was allowed to stir at room temperature for 
24 hrs, at which point the solvent was removed under reduced pressure. The resulting 
yellow solid was then washed with diethyl ether (10 mL, 3x) and collected via vacuum 
filtration, yielding the final product as a yellow solid (200 mg, 30%). 
 
Figure A.15. Synthesis of imidazolidinone 5C. 
 
Synthesis of 5C 
 Compound 5 (500 mg, 2.14 mol) was dissolved into a minimal amount of 
methanol (2 mL) in a six dram vial, followed by addition of 10 (375 mg, 2.35 mmol) to 
the reaction vessel via syringe. The mixture was allowed to stir at room temperature for 
24 hrs, at which point the solvent was removed under reduced pressure. The resulting 
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yellow solid was then washed with diethyl ether (10 mL, 3x) and collected via vacuum 
filtration, yielding the final product as a yellow solid (337 mg, 50%). 
 
Figure A.16. Synthesis of imidazolidinone 6C. 
 
Synthesis of 6C 
 Compound 6 (500 mg, 2.30 mmol) was dissolved into a minimal amount of 
methanol (2 mL) in a six dram vial, followed by addition of 10 (400 mg, 2.53 mmol) to 
the reaction vessel via syringe. The mixture was allowed to stir at room temperature for 
24 hrs, at which point the solvent was removed under reduced pressure. The resulting 
yellow solid was then washed with diethyl ether (10 mL, 3x) and collected via vacuum 
filtration, yielding the final product as a yellow solid (240 mg, 35%). 
 
Figure A.17. Synthesis of imidazolidinone 7C. 
 
Synthesis of 7C 
 Compound 7 (500 mg, 2.02 mmol) was dissolved into a minimal amount of 
methanol (2 mL) in a six dram vial, followed by addition of 10 (354 mg, 2.22 mmol) to 
the reaction vessel via syringe. The mixture was allowed to stir at room temperature for 
24 hrs, at which point the solvent was removed under reduced pressure. The resulting 
yellow solid was then washed with diethyl ether (10 mL, 3x) and collected via vacuum 
filtration, yielding the final product as a yellow solid (280 mg, 44%). 
 102 
 
Figure 1.18. Synthesis of imidazolidinone 8C. 
 
Synthesis of 8C 
 Compound 8 (500 mg, 2.14 mmol) was dissolved into a minimal amount of 
methanol (2 mL) in a six dram vial, followed by addition of 10 (375 mg, 2.35 mmol) to 
the reaction vessel via syringe. The mixture was allowed to stir at room temperature for 
24 hrs, at which point the solvent was removed under reduced pressure. The resulting 
yellow solid was then washed with diethyl ether (10 mL, 3x) and collected via vacuum 
filtration, yielding the final product as a yellow solid (208 mg, 31%). 
 
Figure 1.19. Synthesis of imidazolidinone 9C. 
 
Synthesis of 9C 
 Compound 9 (500 mg, 0.00182 mol) was dissolved into a minimal amount of 
methanol (2 mL) in a six dram vial, followed by addition of 10 (318 mg, 1.1 mol eq.) to 
the reaction vessel via syringe. The mixture was allowed to stir at room temperature for 
24 hrs, at which point the solvent was removed under reduced pressure. The resulting 
yellow solid was then washed with diethyl ether (10 mL, 3x) and collected via vacuum 
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RGB RAW DATA FOR MANOVA ANALYSIS OF ORGANIC ACID 
FLUOROPHORE ARRAY 








4-Hydroxybenzoic acid 0 13 22 
4-Hydroxybenzoic acid 0 14 23 
4-Hydroxybenzoic acid 4 15 24 
4-Hydroxyphenylacetic acid 0 33 25 
4-Hydroxyphenylacetic acid 0 35 26 
4-Hydroxyphenylacetic acid 0 33 22 
Ibuprofen 0 9 21 
Ibuprofen 0 8 18 
Ibuprofen 0 9 15 
Aspirin 0 45 53 
Aspirin 0 44 51 
Aspirin 0 44 50 
Phenylacetic acid 0 27 53 
Phenylacetic acid 0 26 49 
Phenylacetic acid 0 30 54 
4-Chlorophenylacetic acid 0 32 0 
4-Chlorophenylacetic acid 0 30 0 
4-Chlorophenylacetic acid 1 35 0 
Benzoic acid 0 8 39 
Benzoic acid 0 6 33 
Benzoic acid 0 7 27 
3,5-Dihydroxybenzoic acid 0 9 65 
3,5-Dihydroxybenzoic acid 0 8 62 
3,5-Dihydroxybenzoic acid 0 9 55 
2,4-Dichlorobenzoic acid 93 209 71 
2,4-Dichlorobenzoic acid 98 209 71 
2,4-Dichlorobenzoic acid 97 210 64 
5-Iodosalicylic acid 83 162 22 
5-Iodosalicylic acid 85 163 21 














4-Hydroxybenzoic acid 34 56 43 
4-Hydroxybenzoic acid 31 56 44 
4-Hydroxybenzoic acid 36 55 43 
4-Hydroxyphenylacetic acid 21 26 28 
4-Hydroxyphenylacetic acid 19 28 31 
4-Hydroxyphenylacetic acid 17 26 26 
Ibuprofen 25 22 13 
Ibuprofen 24 22 16 
Ibuprofen 22 21 13 
Aspirin 28 32 30 
Aspirin 22 33 34 
Aspirin 23 32 30 
Phenylacetic acid 25 28 53 
Phenylacetic acid 26 30 36 
Phenylacetic acid 25 30 36 
4-Chlorophenylacetic acid 3 14 0 
4-Chlorophenylacetic acid 3 13 0 
4-Chlorophenylacetic acid 2 13 0 
Benzoic acid 4 4 7 
Benzoic acid 3 4 9 
Benzoic acid 3 3 6 
3,5-Dihydroxybenzoic acid 57 96 84 
3,5-Dihydroxybenzoic acid 55 98 87 
3,5-Dihydroxybenzoic acid 54 97 84 
2,4-Dichlorobenzoic acid 76 186 117 
2,4-Dichlorobenzoic acid 75 185 119 
2,4-Dichlorobenzoic acid 75 186 115 
5-Iodosalicylic acid 40 147 88 
5-Iodosalicylic acid 40 148 93 
5-Iodosalicylic acid 39 146 90 
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4-Hydroxybenzoic acid 103 128 0 
4-Hydroxybenzoic acid 108 132 0 
4-Hydroxybenzoic acid 107 129 0 
4-Hydroxyphenylacetic acid 105 102 0 
4-Hydroxyphenylacetic acid 106 102 0 
4-Hydroxyphenylacetic acid 107 103 0 
Ibuprofen 52 51 9 
Ibuprofen 54 55 10 
Ibuprofen 53 52 12 
Aspirin 141 163 32 
Aspirin 143 165 35 
Aspirin 142 164 33 
Phenylacetic acid 25 45 26 
Phenylacetic acid 24 44 24 
Phenylacetic acid 24 46 25 
4-Chlorophenylacetic acid 58 32 0 
4-Chlorophenylacetic acid 59 39 0 
4-Chlorophenylacetic acid 57 31 0 
Benzoic acid 78 129 0 
Benzoic acid 75 128 0 
Benzoic acid 76 128 0 
3,5-Dihydroxybenzoic acid 52 72 17 
3,5-Dihydroxybenzoic acid 50 68 12 
3,5-Dihydroxybenzoic acid 49 69 13 
2,4-Dichlorobenzoic acid 116 170 0 
2,4-Dichlorobenzoic acid 115 169 0 
2,4-Dichlorobenzoic acid 115 171 0 
5-Iodosalicylic acid 222 198 0 
5-Iodosalicylic acid 223 197 0 




Table B.4. RGB data taken of XF1 in DMF. 
 
 




DMF XF1  
B 
4-Hydroxybenzoic acid 59 52 0 
4-Hydroxybenzoic acid 59 54 0 
4-Hydroxybenzoic acid 60 55 0 
4-Hydroxyphenylacetic acid 0 0 0 
4-Hydroxyphenylacetic acid 0 0 0 
4-Hydroxyphenylacetic acid 0 0 0 
Ibuprofen 18 10 0 
Ibuprofen 17 9 0 
Ibuprofen 17 10 0 
Aspirin 39 33 0 
Aspirin 35 31 0 
Aspirin 35 32 0 
Phenylacetic acid 45 44 12 
Phenylacetic acid 44 45 7 
Phenylacetic acid 43 43 3 
4-Chlorophenylacetic acid 28 4 0 
4-Chlorophenylacetic acid 29 5 0 
4-Chlorophenylacetic acid 30 5 0 
Benzoic acid 36 34 11 
Benzoic acid 35 35 8 
Benzoic acid 38 36 8 
3,5-Dihydroxybenzoic acid 74 69 10 
3,5-Dihydroxybenzoic acid 74 69 8 
3,5-Dihydroxybenzoic acid 71 67 8 
2,4-Dichlorobenzoic acid 125 134 8 
2,4-Dichlorobenzoic acid 124 133 6 
2,4-Dichlorobenzoic acid 124 134 9 
5-Iodosalicylic acid 150 123 0 
5-Iodosalicylic acid 151 120 0 













4-Hydroxybenzoic acid 28 51 34 
4-Hydroxybenzoic acid 26 50 36 
4-Hydroxybenzoic acid 26 51 39 
4-Hydroxyphenylacetic acid 0 14 1 
4-Hydroxyphenylacetic acid 0 10 0 
4-Hydroxyphenylacetic acid 0 12 1 
Ibuprofen 0 0 0 
Ibuprofen 0 0 0 
Ibuprofen 0 0 0 
Aspirin 12 29 25 
Aspirin 13 27 26 
Aspirin 11 27 28 
Phenylacetic acid 31 58 53 
Phenylacetic acid 34 57 57 
Phenylacetic acid 35 53 57 
4-Chlorophenylacetic acid 0 0 0 
4-Chlorophenylacetic acid 0 0 0 
4-Chlorophenylacetic acid 0 0 0 
Benzoic acid 5 17 18 
Benzoic acid 10 16 19 
Benzoic acid 13 15 21 
3,5-Dihydroxybenzoic acid 0 34 44 
3,5-Dihydroxybenzoic acid 0 32 42 
3,5-Dihydroxybenzoic acid 0 32 39 
2,4-Dichlorobenzoic acid 21 125 58 
2,4-Dichlorobenzoic acid 18 124 58 
2,4-Dichlorobenzoic acid 22 123 61 
5-Iodosalicylic acid 14 127 70 
5-Iodosalicylic acid 13 136 70 













4-Hydroxybenzoic acid 16 33 0 
4-Hydroxybenzoic acid 17 33 0 
4-Hydroxybenzoic acid 15 31 0 
4-Hydroxyphenylacetic acid 0 15 0 
4-Hydroxyphenylacetic acid 0 13 0 
4-Hydroxyphenylacetic acid 0 14 0 
Ibuprofen 21 44 0 
Ibuprofen 23 42 0 
Ibuprofen 23 43 0 
Aspirin 54 100 0 
Aspirin 51 99 0 
Aspirin 50 101 0 
Phenylacetic acid 0 43 22 
Phenylacetic acid 0 41 26 
Phenylacetic acid 0 42 25 
4-Chlorophenylacetic acid 0 0 0 
4-Chlorophenylacetic acid 0 0 0 
4-Chlorophenylacetic acid 0 0 0 
Benzoic acid 0 40 42 
Benzoic acid 0 38 41 
Benzoic acid 0 37 38 
3,5-Dihydroxybenzoic acid 52 129 50 
3,5-Dihydroxybenzoic acid 53 127 51 
3,5-Dihydroxybenzoic acid 55 128 52 
2,4-Dichlorobenzoic acid 81 167 0 
2,4-Dichlorobenzoic acid 82 166 0 
2,4-Dichlorobenzoic acid 80 165 0 
5-Iodosalicylic acid 141 167 36 
5-Iodosalicylic acid 136 164 33 













4-Hydroxybenzoic acid 0 2 0 
4-Hydroxybenzoic acid 0 3 0 
4-Hydroxybenzoic acid 0 1 0 
4-Hydroxyphenylacetic acid 0 10 0 
4-Hydroxyphenylacetic acid 0 11 0 
4-Hydroxyphenylacetic acid 0 9 0 
Ibuprofen 5 19 0 
Ibuprofen 2 18 0 
Ibuprofen 4 18 0 
Aspirin 61 82 0 
Aspirin 58 82 0 
Aspirin 56 84 0 
Phenylacetic acid 0 18 0 
Phenylacetic acid 0 15 0 
Phenylacetic acid 0 14 0 
4-Chlorophenylacetic acid 0 0 0 
4-Chlorophenylacetic acid 0 0 0 
4-Chlorophenylacetic acid 0 0 0 
Benzoic acid 0 0 0 
Benzoic acid 0 0 0 
Benzoic acid 0 0 0 
3,5-Dihydroxybenzoic acid 0 0 0 
3,5-Dihydroxybenzoic acid 0 0 0 
3,5-Dihydroxybenzoic acid 0 0 0 
2,4-Dichlorobenzoic acid 233 56 0 
2,4-Dichlorobenzoic acid 232 55 0 
2,4-Dichlorobenzoic acid 230 58 0 
5-Iodosalicylic acid 203 56 0 
5-Iodosalicylic acid 201 58 0 













4-Hydroxybenzoic acid 18 74 0 
4-Hydroxybenzoic acid 20 75 0 
4-Hydroxybenzoic acid 18 74 0 
4-Hydroxyphenylacetic acid 0 45 0 
4-Hydroxyphenylacetic acid 0 46 0 
4-Hydroxyphenylacetic acid 0 49 0 
Ibuprofen 6 47 0 
Ibuprofen 7 50 0 
Ibuprofen 9 49 0 
Aspirin 32 83 0 
Aspirin 32 85 0 
Aspirin 31 88 0 
Phenylacetic acid 0 41 0 
Phenylacetic acid 0 42 0 
Phenylacetic acid 0 41 0 
4-Chlorophenylacetic acid 0 24 0 
4-Chlorophenylacetic acid 0 25 0 
4-Chlorophenylacetic acid 0 26 0 
Benzoic acid 0 37 0 
Benzoic acid 0 38 0 
Benzoic acid 0 35 0 
3,5-Dihydroxybenzoic acid 111 139 0 
3,5-Dihydroxybenzoic acid 108 134 0 
3,5-Dihydroxybenzoic acid 109 137 0 
2,4-Dichlorobenzoic acid 218 85 0 
2,4-Dichlorobenzoic acid 222 82 0 
2,4-Dichlorobenzoic acid 219 81 0 
5-Iodosalicylic acid 180 155 0 
5-Iodosalicylic acid 181 153 0 
5-Iodosalicylic acid 179 155 0 
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4-Hydroxybenzoic acid 0 0 0 
4-Hydroxybenzoic acid 0 0 0 
4-Hydroxybenzoic acid 0 0 0 
4-Hydroxyphenylacetic 
acid 88 0 0 
4-Hydroxyphenylacetic 
acid 86 0 0 
4-Hydroxyphenylacetic 
acid 87 0 0 
Ibuprofen 5 0 0 
Ibuprofen 3 0 0 
Ibuprofen 4 0 0 
Aspirin 0 0 0 
Aspirin 0 0 0 
Aspirin 0 0 0 
Phenylacetic acid 47 0 0 
Phenylacetic acid 48 0 0 
Phenylacetic acid 50 0 0 
4-Chlorophenylacetic acid 19 0 0 
4-Chlorophenylacetic acid 17 0 0 
4-Chlorophenylacetic acid 20 0 0 
Benzoic acid 28 0 0 
Benzoic acid 22 0 0 
Benzoic acid 24 0 0 
3,5-Dihydroxybenzoic acid 154 0 0 
3,5-Dihydroxybenzoic acid 153 0 0 
3,5-Dihydroxybenzoic acid 150 0 0 
2,4-Dichlorobenzoic acid 161 0 0 
2,4-Dichlorobenzoic acid 155 0 0 
2,4-Dichlorobenzoic acid 163 0 0 
5-Iodosalicylic acid 184 0 0 
5-Iodosalicylic acid 182 0 0 













4-Hydroxybenzoic acid 0 0 0 
4-Hydroxybenzoic acid 0 0 0 
4-Hydroxybenzoic acid 0 0 0 
4-Hydroxyphenylacetic acid 0 0 0 
4-Hydroxyphenylacetic acid 0 0 0 
4-Hydroxyphenylacetic acid 0 0 0 
Ibuprofen 0 0 0 
Ibuprofen 0 0 0 
Ibuprofen 0 0 0 
Aspirin 0 0 19 
Aspirin 0 0 17 
Aspirin 0 0 20 
Phenylacetic acid 22 0 0 
Phenylacetic acid 21 0 0 
Phenylacetic acid 20 0 0 
4-Chlorophenylacetic acid 0 0 0 
4-Chlorophenylacetic acid 0 0 0 
4-Chlorophenylacetic acid 0 0 0 
Benzoic acid 5 0 0 
Benzoic acid 1 0 0 
Benzoic acid 4 0 0 
3,5-Dihydroxybenzoic acid 69 0 0 
3,5-Dihydroxybenzoic acid 70 0 0 
3,5-Dihydroxybenzoic acid 71 0 0 
2,4-Dichlorobenzoic acid 86 0 0 
2,4-Dichlorobenzoic acid 88 0 0 
2,4-Dichlorobenzoic acid 85 0 0 
5-Iodosalicylic acid 171 0 0 
5-Iodosalicylic acid 170 0 2 













4-Hydroxybenzoic acid 28 59 0 
4-Hydroxybenzoic acid 29 60 0 
4-Hydroxybenzoic acid 30 60 0 
4-Hydroxyphenylacetic acid 17 39 0 
4-Hydroxyphenylacetic acid 18 40 0 
4-Hydroxyphenylacetic acid 21 41 0 
Ibuprofen 0 7 0 
Ibuprofen 0 5 0 
Ibuprofen 0 6 0 
Aspirin 0 55 0 
Aspirin 0 54 0 
Aspirin 0 53 0 
Phenylacetic acid 33 60 0 
Phenylacetic acid 32 60 0 
Phenylacetic acid 32 58 0 
4-Chlorophenylacetic acid 0 1 0 
4-Chlorophenylacetic acid 0 0 0 
4-Chlorophenylacetic acid 0 0 0 
Benzoic acid 0 7 0 
Benzoic acid 0 8 0 
Benzoic acid 1 9 0 
3,5-Dihydroxybenzoic acid 125 66 0 
3,5-Dihydroxybenzoic acid 124 67 0 
3,5-Dihydroxybenzoic acid 127 65 0 
2,4-Dichlorobenzoic acid 177 44 0 
2,4-Dichlorobenzoic acid 179 49 0 
2,4-Dichlorobenzoic acid 178 47 0 
5-Iodosalicylic acid 169 128 0 
5-Iodosalicylic acid 170 129 0 













4-Hydroxybenzoic acid 0 0 0 
4-Hydroxybenzoic acid 0 0 0 
4-Hydroxybenzoic acid 0 0 0 
4-Hydroxyphenylacetic acid 0 0 0 
4-Hydroxyphenylacetic acid 0 0 0 
4-Hydroxyphenylacetic acid 0 0 0 
Ibuprofen 0 0 0 
Ibuprofen 0 0 0 
Ibuprofen 0 0 0 
Aspirin 0 0 0 
Aspirin 1 0 0 
Aspirin 2 0 0 
Phenylacetic acid 2 0 0 
Phenylacetic acid 5 0 0 
Phenylacetic acid 4 0 0 
4-Chlorophenylacetic acid 0 0 0 
4-Chlorophenylacetic acid 0 0 0 
4-Chlorophenylacetic acid 0 0 0 
Benzoic acid 26 0 0 
Benzoic acid 31 0 0 
Benzoic acid 28 0 0 
3,5-Dihydroxybenzoic acid 115 0 0 
3,5-Dihydroxybenzoic acid 118 0 0 
3,5-Dihydroxybenzoic acid 116 0 0 
2,4-Dichlorobenzoic acid 64 0 0 
2,4-Dichlorobenzoic acid 63 0 0 
2,4-Dichlorobenzoic acid 66 0 0 
5-Iodosalicylic acid 167 0 0 
5-Iodosalicylic acid 168 0 0 













4-Hydroxybenzoic acid 0 0 1 
4-Hydroxybenzoic acid 0 0 2 
4-Hydroxybenzoic acid 0 0 5 
4-Hydroxyphenylacetic acid 0 0 0 
4-Hydroxyphenylacetic acid 0 0 0 
4-Hydroxyphenylacetic acid 0 0 0 
Ibuprofen 0 0 124 
Ibuprofen 0 0 125 
Ibuprofen 0 0 129 
Aspirin 0 8 206 
Aspirin 0 10 209 
Aspirin 0 9 206 
Phenylacetic acid 0 0 138 
Phenylacetic acid 0 0 137 
Phenylacetic acid 0 0 134 
4-Chlorophenylacetic acid 0 0 211 
4-Chlorophenylacetic acid 0 0 214 
4-Chlorophenylacetic acid 0 0 212 
Benzoic acid 0 0 138 
Benzoic acid 0 0 140 
Benzoic acid 0 0 139 
3,5-Dihydroxybenzoic acid 0 0 0 
3,5-Dihydroxybenzoic acid 0 0 0 
3,5-Dihydroxybenzoic acid 0 0 0 
2,4-Dichlorobenzoic acid 0 0 178 
2,4-Dichlorobenzoic acid 0 0 179 
2,4-Dichlorobenzoic acid 0 0 182 
5-Iodosalicylic acid 0 0 227 
5-Iodosalicylic acid 0 0 225 













4-Hydroxybenzoic acid 8 0 19 
4-Hydroxybenzoic acid 11 0 19 
4-Hydroxybenzoic acid 10 0 18 
4-Hydroxyphenylacetic acid 22 0 25 
4-Hydroxyphenylacetic acid 21 0 23 
4-Hydroxyphenylacetic acid 25 0 26 
Ibuprofen 0 55 0 
Ibuprofen 0 53 0 
Ibuprofen 0 54 0 
Aspirin 0 0 79 
Aspirin 0 0 78 
Aspirin 0 0 80 
Phenylacetic acid 0 0 82 
Phenylacetic acid 0 0 81 
Phenylacetic acid 0 0 80 
4-Chlorophenylacetic acid 0 0 79 
4-Chlorophenylacetic acid 0 0 80 
4-Chlorophenylacetic acid 0 0 81 
Benzoic acid 0 0 70 
Benzoic acid 0 0 74 
Benzoic acid 0 0 73 
3,5-Dihydroxybenzoic acid 26 0 23 
3,5-Dihydroxybenzoic acid 21 0 24 
3,5-Dihydroxybenzoic acid 25 0 24 
2,4-Dichlorobenzoic acid 0 0 145 
2,4-Dichlorobenzoic acid 0 0 144 
2,4-Dichlorobenzoic acid 0 0 143 
5-Iodosalicylic acid 0 26 92 
5-Iodosalicylic acid 0 23 92 













4-Hydroxybenzoic acid 0 0 126 
4-Hydroxybenzoic acid 0 0 125 
4-Hydroxybenzoic acid 0 0 124 
4-Hydroxyphenylacetic acid 0 78 221 
4-Hydroxyphenylacetic acid 0 80 221 
4-Hydroxyphenylacetic acid 0 79 220 
Ibuprofen 0 0 152 
Ibuprofen 0 0 153 
Ibuprofen 0 0 151 
Aspirin 0 54 251 
Aspirin 0 58 255 
Aspirin 0 56 255 
Phenylacetic acid 0 0 243 
Phenylacetic acid 0 0 246 
Phenylacetic acid 0 0 245 
4-Chlorophenylacetic acid 0 0 255 
4-Chlorophenylacetic acid 0 0 254 
4-Chlorophenylacetic acid 0 0 255 
Benzoic acid 0 0 255 
Benzoic acid 0 0 253 
Benzoic acid 0 0 254 
3,5-Dihydroxybenzoic acid 0 28 131 
3,5-Dihydroxybenzoic acid 0 29 131 
3,5-Dihydroxybenzoic acid 0 31 133 
2,4-Dichlorobenzoic acid 0 3 245 
2,4-Dichlorobenzoic acid 0 4 244 
2,4-Dichlorobenzoic acid 0 2 241 
5-Iodosalicylic acid 0 18 190 
5-Iodosalicylic acid 0 17 187 













4-Hydroxybenzoic acid 96 57 13 
4-Hydroxybenzoic acid 91 60 16 
4-Hydroxybenzoic acid 94 59 14 
4-Hydroxyphenylacetic acid 92 50 0 
4-Hydroxyphenylacetic acid 91 49 0 
4-Hydroxyphenylacetic acid 93 48 0 
Ibuprofen 50 12 0 
Ibuprofen 51 13 0 
Ibuprofen 47 12 0 
Aspirin 31 8 2 
Aspirin 33 11 6 
Aspirin 31 10 4 
Phenylacetic acid 49 11 0 
Phenylacetic acid 47 14 0 
Phenylacetic acid 52 14 0 
4-Chlorophenylacetic acid 29 2 0 
4-Chlorophenylacetic acid 24 0 0 
4-Chlorophenylacetic acid 26 0 1 
Benzoic acid 23 0 0 
Benzoic acid 24 0 0 
Benzoic acid 25 0 0 
3,5-Dihydroxybenzoic acid 73 26 0 
3,5-Dihydroxybenzoic acid 74 25 0 
3,5-Dihydroxybenzoic acid 66 23 0 
2,4-Dichlorobenzoic acid 0 13 97 
2,4-Dichlorobenzoic acid 0 15 99 
2,4-Dichlorobenzoic acid 0 16 100 
5-Iodosalicylic acid 0 42 128 
5-Iodosalicylic acid 0 40 127 













4-Hydroxybenzoic acid 0 0 9 
4-Hydroxybenzoic acid 0 0 10 
4-Hydroxybenzoic acid 0 0 12 
4-Hydroxyphenylacetic acid 0 0 0 
4-Hydroxyphenylacetic acid 0 0 0 
4-Hydroxyphenylacetic acid 0 0 0 
Ibuprofen 0 5 0 
Ibuprofen 0 7 0 
Ibuprofen 0 3 0 
Aspirin 0 0 2 
Aspirin 0 0 3 
Aspirin 0 0 5 
Phenylacetic acid 0 0 23 
Phenylacetic acid 0 0 24 
Phenylacetic acid 0 0 22 
4-Chlorophenylacetic acid 0 0 30 
4-Chlorophenylacetic acid 0 0 31 
4-Chlorophenylacetic acid 0 0 29 
Benzoic acid 0 0 65 
Benzoic acid 0 0 64 
Benzoic acid 0 0 67 
3,5-Dihydroxybenzoic acid 0 0 0 
3,5-Dihydroxybenzoic acid 0 0 0 
3,5-Dihydroxybenzoic acid 0 0 0 
2,4-Dichlorobenzoic acid 0 0 176 
2,4-Dichlorobenzoic acid 0 0 177 
2,4-Dichlorobenzoic acid 0 0 178 
5-Iodosalicylic acid 0 73 131 
5-Iodosalicylic acid 0 76 133 













4-Hydroxybenzoic acid 0 0 43 
4-Hydroxybenzoic acid 0 0 41 
4-Hydroxybenzoic acid 0 0 40 
4-Hydroxyphenylacetic acid 0 13 102 
4-Hydroxyphenylacetic acid 0 14 104 
4-Hydroxyphenylacetic acid 0 13 103 
Ibuprofen 0 0 117 
Ibuprofen 0 0 115 
Ibuprofen 0 0 116 
Aspirin 0 7 255 
Aspirin 0 8 255 
Aspirin 0 5 255 
Phenylacetic acid 0 0 130 
Phenylacetic acid 0 0 132 
Phenylacetic acid 0 0 134 
4-Chlorophenylacetic acid 0 0 228 
4-Chlorophenylacetic acid 0 0 231 
4-Chlorophenylacetic acid 0 0 232 
Benzoic acid 0 0 249 
Benzoic acid 0 0 247 
Benzoic acid 0 0 250 
3,5-Dihydroxybenzoic acid 0 20 95 
3,5-Dihydroxybenzoic acid 0 21 95 
3,5-Dihydroxybenzoic acid 0 19 95 
2,4-Dichlorobenzoic acid 0 0 222 
2,4-Dichlorobenzoic acid 0 0 223 
2,4-Dichlorobenzoic acid 0 0 224 
5-Iodosalicylic acid 0 32 163 
5-Iodosalicylic acid 0 31 164 


















1 0 0 0 
1 0 0 0 
1 0 0 0 
2 0 0 0 
2 0 0 0 
2 0 0 0 
3 0 0 0 
3 0 0 0 
3 0 0 0 
4 0 0 0 
4 0 0 0 
4 0 0 0 
5 0 0 0 
5 0 0 0 
5 0 0 0 
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1 0 0 0 
1 73 98 0 
1 75 97 0 
2 74 98 0 
2 0 0 0 
2 0 0 0 
3 0 0 0 
3 0 0 0 
3 0 0 0 
4 0 0 0 
4 0 0 0 
4 0 0 0 
5 68 67 0 
5 63 61 0 
5 68 64 0 
 









1 0 0 0 
1 0 0 0 
1 0 0 0 
2 0 35 4 
2 0 38 7 
2 0 33 2 
3 0 0 0 
3 0 0 0 
3 0 0 0 
4 0 0 0 
4 0 0 0 
4 0 0 0 
5 44 95 14 
5 47 96 10 
5 45 98 14 
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1 0 14 0 
1 2 17 0 
1 1 15 0 
2 0 6 0 
2 0 4 0 
2 0 5 0 
3 0 16 0 
3 0 14 0 
3 0 17 0 
4 5 11 0 
4 6 11 0 
4 7 12 0 
5 5 26 0 
5 6 27 0 
5 7 28 0 
 









1 0 0 0 
1 0 0 0 
1 0 0 0 
2 95 0 0 
2 94 0 0 
2 97 0 0 
3 10 0 0 
3 11 0 0 
3 9 0 0 
4 25 0 0 
4 27 0 0 
4 28 0 0 
5 127 0 0 
5 128 0 0 
5 132 0 0 
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1 0 0 0 
1 0 0 0 
1 0 0 0 
2 17 0 0 
2 19 0 0 
2 22 0 0 
3 48 0 0 
3 46 0 0 
3 45 0 0 
4 17 0 0 
4 18 0 0 
4 16 0 0 
5 102 0 0 
5 104 0 0 
5 106 0 0 
 
 









1 0 0 113 
1 0 0 112 
1 0 0 110 
2 0 25 10 
2 0 21 7 
2 0 22 10 
3 0 0 146 
3 0 0 147 
3 0 0 148 
4 0 0 188 
4 0 0 191 
4 0 0 187 
5 13 62 1 
5 15 63 2 
5 17 67 5 
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1 0 0 50 
1 0 0 49 
1 0 0 52 
2 0 14 127 
2 0 13 126 
2 0 16 128 
3 0 0 141 
3 0 0 137 
3 0 0 142 
4 0 0 172 
4 0 0 174 
4 0 0 171 
5 0 0 44 
5 0 0 52 
5 0 0 54 
 
 









1 0 9 103 
1 0 0 101 
1 0 0 102 
2 0 9 59 
2 0 9 60 
2 0 10 62 
3 0 0 166 
3 0 0 162 
3 0 0 163 
4 0 0 139 
4 0 0 135 
4 0 0 138 
5 0 62 52 
5 0 68 55 
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